Abstract
The review briefly summarizes the role of the family of adhesion molecules, JAMs (junctional adhesion molecules), in various cell migration, covering germ cells, epithelial cells, endothelial cells, several leukocytes, and different cancer cells. These functions affect multiple diseases, including reproductive diseases, inflammation-related diseases, cardiovascular diseases, and cancers. JAMs bind to both similar and dissimilar proteins and take both similar and dissimilar effects on different cells. Concluding relevant results provides a reference to further research.
Introduction
Cell migration plays a pivotal role in tissue organization during development, and several diseases develop due to its dysregulation. The migration properties are partly dictated by cell adhesion and its endocytic regulation, and scaffold cell-dependent migration could be represented among various types of migration (Kawauchi 2012). It is critical to maintain junctional integrity during cell migration and cell extrusion through classic cell–cell junctions member protein such as ZO-1 (). Transmembrane and associated cytoplasmic proteins in tight junctions show dynamic behavior, including migration within the junction and exchange in and out of the junctions (). In addition, internalized tight junctions (TJs) proteins are recycled to the plasma membrane or sorted to late endosomes and degradation (Stamatovic et al., 2017).
Junctional adhesion molecule (JAM) is a member of the immunoglobulin superfamily localized at the tight junction of polarized cells and on the cell surface of leukocytes (). Several members of the family mediate cell polarity, endothelium permeability, and leukocytes migration through a multitude of homophilic and heterophilic interactions with intrafamily and extrafamily partners (Garrido-Urbani et al., 2014). Several members of the JAM family interact with PDZ domain-containing scaffolding proteins such as ZO-1, claudin, and afadin, regulating cell–cell contact maturation and the generation of junctional complexes such as TJs and adherens junctions (AJs) (Keiper et al., 2005a; ; Hartmann et al., 2020). In the early years, there existed some inconsistencies in the JAM nomenclature. In this review, we quote the original description of these articles and specific information referring to the review of Mandell and Parkos (Mandell and Parkos 2005).
Germ Cell Motility, Polarization, and Maturation
Germ cells (GCs) migrate spatially distinct locations for proper development with various patterns; nevertheless, the reason and cellular mechanisms that facilitate germ cells motility and guide migration in vivo remain unclear (Kanamori et al., 2019; Grimaldi and Raz 2020). The adhesive interaction between germ and Sertoli cells (SCs) regulates spermatogenesis ().
Among all members and family-related molecules, JAM-C could be the most striking protein modulating germ cell activities. JAM-C localizes to germ/Sertoli cell contacts and participates in acrosome formation and germ cell polarity, specifically round spermatids. Intriguingly, JAM-C is restricted to the apical ectoplasmic specialization (ES) but not at the blood–testis barrier (BTB) in mouse testes. Par6, Cdc42, PKCl, and PATJ are identified as the downstream of engaged JAM-C protein, mediating spermatid polarization in mice and possibly in humans together (Gliki et al., 2004). Furthermore, Par6 formed a stable complex with Pals1 and JAM-C in normal testes, and the tight association of the Par6/Pals1 complex with Src kinase rendered a loss of association of the Par6/Pals1 complex with JAM-C, thereby destabilizing apical ES to facilitate spermatid loss (Wong et al., 2008). Additionally, RA175 formed a ternary complex with JAM-C via interaction with Par-3, which may take effect when the specialized adhesion structures of elongating spermatid form (). Another demonstrated partner of JAM-C is CAR, and they both are components of apical ES involved in spermatid orientation, facilitating cell movement and orientation in the seminiferous epithelium (Mirza et al., 2006; Yan et al., 2007). Unfortunately, another research instead implied that JAM-C controlled germ cell differentiation without reference to CAR and the interaction between CAR and JAML, meanwhile, appears not to confer transepithelial migration of cells in the BTB (Sultana et al., 2014). Jam-C-deficient males are infertile and fail to produce mature sperm cells with about 50% smaller testes and lacks differentiated elongated spermatids (Gliki et al., 2004). Similarly, Spo11(Cre) mice crossed with floxed JAM-C mice to produce conditional knockouts and showed a strong reduction of JAM-C protein levels in the testis and a spermiogenetic arrest (Pellegrini et al., 2011).
JAM-A is present in the prostate and seminal vesicles and all three regions of the epididymis. JAM-A is located at both Sertoli and a subset of basal GCs, specifically in inter-Sertoli cell junctions and the tails of elongated spermatids within the epididymis of rodents, secreted in epididymosomes in the luminal fluid, and delivered to sperm in vitro (Shao et al., 2008; Wu et al., 2017). When the Sertoli cell tight junction was perturbed in vitro, BTB-associated proteins JAM-A disappear from the cell–cell interface (Xia et al., 2007). At the time of germ cell migration across the BTB during spermatogenesis, the TJ- and AJ-integral membrane proteins (including JAM-1) can be disengaged to facilitate AJ restructuring, accommodating germ cell migration while maintaining the BTB integrity (Yan and Cheng 2005). JAM-A expressed in premeiotic GCs facilitates GC migration through the BTB and then disappears in most GCs resident in the adluminal compartment, and CAR has mechanisms similar to localization and involvement in GC migration (Wang and Cheng 2007; Wang et al., 2007; Tarulli et al., 2008). JAM-A reactivity declined in Sertoli cells from tubules with testicular carcinoma in situ (CIS) and emerged to be strong in seminoma (Tarulli et al., 2013). sGCb1 plays an important role in the restructuring of the adherent junction in the testis, which seems associated with JAM-A (Sarkar et al., 2006). The presence of TGF-β3 and TNFα enhanced the kinetics of endocytosis of JAM-A from the Sertoli cell surface, and TGF-β3 disrupted JAM-A-based TJ fibrils (Xia et al., 2009). More association between P-glycoprotein (P-gp, MDR1) and JAM-A possibly enhanced BTB function (Su et al., 2009). In sperm, Ca2+ homeostasis is sustained by the relative ratios of CASK–PMCA4b and CASK–JAM-A interactions, as JAM-A positively regulates PMCA4b by sequestering CASK under conditions of elevated Ca2+ (). Multiple stimuli have been shown to affect JAM-A function. Cyproterone acetate (CPA) could somehow reduce the kinetics of internalization of JAM-A, whose maintenance impliedly requires a very low level of endogenous testosterone (Yan et al., 2008). C-type natriuretic peptide (CNP) produced by Sertoli and germ cells into the BTB microenvironment accelerates endocytosis of JAM-A and opens the BTB transiently to encourage preleptotene spermatocyte migration (Xia et al., 2007). Excess iodine causes loss of spermatogenesis by disrupting the blood–testis barrier and cytoskeleton, with reduced expression of JAM-A in blood–testis barrier proteins (). The commercial polychlorinated biphenyls mixture, Aroclor1254 treatment, could induce increments in JAM-A endocytosis and occludin ubiquitination in primary cultured SCs and rats (Jia et al., 2017). In addition, oxidative damage participates in heat stress-induced downregulation of tight junction proteins in Sertoli cells by inhibiting the CaMKKβ–AMPK axis in boars, which was reversed by N-acetyl-l-cysteine (NAC) (Yang et al., 2020). IL-6 treatment delayed the kinetics of JAM-A, leading to accumulation in Sertoli cells (Zhang et al., 2014). Presently, JAM-A has been regarded as typical BTB-associated integral membrane proteins and several other related proteins mainly including tight junction, ectoplasmic specialization, and adherens junction proteins.
In the mammalian testis, JAM-B occurs in the blood–testis barrier between Sertoli cells and the apical ectoplasmic specializations between Sertoli and germ cells, promoting the transit of developing germ cells across the blood–testis barrier and the timely release of mature spermatids at stage VIII. In MSC-1 cells, the binding of various transcription factors to various cis-acting elements-binding motifs regulates the constitutive expression of JAM-B (Wang and Lui 2009). IL-1alpha promotes JAM-B expression by facilitating the binding of Elk-1 to TG-interacting factor (TGIF) and proximal Sp1 (pSp1) + E2F motifs in a p38-dependent manner, leading to an additive effect on Sp1-and neuron-restrictive silencer factor (NRSF)-mediated JAM-B transactivation (Wang and Lui 2009). Rather, TGF-beta2 inhibits JAM-B transcription via the activation of mothers against decapentaplegic (Smad) proteins, and activated Smads compete with specificity proteins (Sp1 and Sp3) for the TGIF motif, causing JAM-B repression (Wang and Lui 2009). Transforming growth factor-β3 regulates cell junction restructuring via Smad-dependent protein degradation of JAM-B (Zhang and Lui 2015). JAM-A and JAM-B are localized at the BTB, and JAM-C on spermatids interact with JAM-B on the Sertoli cell to foster the morphological polarization of round spermatids to elongated spermatids (). Graspin inhibited the PDZ-mediated interactions of GRASP55 with JAMs, resulting in hampered polarized localization of JAM-C in spermatids, the premature release of spermatids, and the affected Golgi morphology of meiotic spermatocytes (). Another member JAM4 protein could function as a cell adhesion molecule rather than a tight-junction protein in the testis during BTB formation; generally, JAM might participate in homophilic cell adhesion between spermatogonia–spermatogonia, spermatogonia–Sertoli cells, and Sertoli cells–Sertoli cells (Nagamatsu et al., 2006).
Germ cells have impressive and special migration characteristics. In adult rat testes, the blood–testis barrier, TJs between Sertoli cells (), in the seminiferous epithelium must “open” (or “disassemble”) to accommodate the migration of preleptotene spermatocytes from the basal to the adluminal compartment that occurs at stage VIII of the epithelial cycle (Xia et al., 2007). To recap, transepithelial migration of male germ cells across the BTB regulates sperm motility and spermatid differentiation, and JAMs have an exact function to regulate it. The roles of JAMs in germ cell motility, polarization, and maturation have been concluded in Table 1.
TABLE 1
| Protein | Location | Partner | Final effect |
|---|---|---|---|
| JAM-A | Sertoli cell and a subset of basal GCs | P-glycoprotein | Maintains the BTB integrity |
| Su et al. (2009) | |||
| CASK | |||
| JAM-B | BTB between Sertoli and germ cells | JAM-C on spermatids | Promotes germ cells to transit across the BTB |
| Wang and Lui (2009) | |||
| JAM-C | Germ/Sertoli cell | Par6/Pals | Mediates spermatid polarization and differentiation and produces mature sperm cells |
| Wong et al. (2008) | |||
| Par-3 | |||
| CAR | |||
| Sultana et al. (2014) |
JAMs in germ cell motility, polarization, and maturation.
Epithelial and Epidermis Barrier
Keratinocytes, the predominant cell type of the epidermis, migrate to bring tissue reepithelialization and reinstate the epithelial barrier during wound healing (; Holt et al., 2021). JAM-A is expressed in epidermis two-folds higher than that in full-thickness skin predominantly located at the cell–cell interface in the epidermis (Wang et al., 2018). JAM-A knockdown promotes keratinocyte proliferation and migration to improve the skin healing process in vivo, regulated by the signaling of FAK-mediated Erk1/2 activation (Wang et al., 2018). Bioactive glass (BG) extracts a posttranscriptional regulation mechanism on the expression of JAM-A to assemble into TJs located along the edge of the cell membrane, involved in mediating the enhanced barrier function of the keratinocyte monolayers (Tang et al., 2021).
JAM-A cis-homodimers encourage the formation of a complex with afadin and PDZ-GEF2 to enhance cell migration by activating the small GTPase Rap1A, whose active levels are decreased by JAM-A depletion or overexpression of cis-dimerization mutants (Mandell et al., 2005; Severson et al., 2008; Severson and Parkos 2009a; Severson and Parkos 2009b; Severson et al., 2009; Luissint et al., 2014). Additionally, Rap1 activity activation requires N-glycosylation of JAM-A, reinforcing barrier function, as glycosylation of N185 is required for JAM-A-mediated reduction of cell migration (Scott et al., 2015). Interestingly, trans-null but not cis-null JAM-A mutant expression decreased Rap2 activity, which implies trans-dimerization of JAM-A as a barrier-inducing molecular switch (Monteiro et al., 2014). A functional complex comprising JAM-A, α3β1 integrin, and tetraspanins CD151 and CD9 regulated collective cell migration of polarized epithelial cells (Thölmann et al., 2022). JAM-A protein is found at the leading edge of repairing corneal epithelial wounds in wild-type mice, while corneal epithelial wound repair was qualitatively normal, but corneal epithelium cells are irregularly shaped in JAM-A null animals (Kang et al., 2007). JAM-A deletion worsened intestinal hyperpermeability and therefore increases intestinal epithelial migration (Meng et al., 2019). Similarly, in oral epithelial cells, ligation of CD24 induces a c-Src kinase-dependent decrease in paracellular permeability mediated by JAM-A and other tight junction proteins, which also affects migrating epithelium of the periodontitis lesion (Ye et al., 2011). The increase in JAM-A expression following Ykt6 knockdown drives prostate epithelial cell motility by stimulating Rap1 and Rac1 small GTPases, regulated by miR-145 (Naydenov et al., 2018).
Alternatively, JAM-C regulates epithelial cell migration at the level of β1 integrin activity but not integrin expression (Mandicourt et al., 2007; ). JAM-C distributed nonclassically in the apical membranes of Müller cells and retinal pigment epithelial (RPE) (; ), and JAM-C knockdown inhibits human RPE cell migration but not proliferation and decreases the permeability of monolayer hRPE (Hou et al., 2012). JAM3 is expressed in multiciliated cells (MCCs) in the airway epithelium, and JAM3 lacking causes a delay in BB assembly/positioning during MCC differentiation (Mateos-Quiros et al., 2021).
Moreover, JAM-A was often observed for aberrant cytoplasmic expression in diseased gingival tissues and more expression within the leukocytes in disease-associated epithelia (). γδ T cells present epithelial tissue bridge innate and adaptive immunity. More interestingly, the costimulation of JAML with its endogenous ligand CAR or by binding to the stimulatory antibody HL4E10 activates epithelial γδ T cells, leading to cellular proliferation, migration, and adhesion (Witherden et al., 2010; Verdino et al., 2011; Johnson et al., 2021).
Overall, JAMs regulate the migration process of multiple epithelial cells in different but connected ways, whose mechanisms remain to be explored. Conspicuously, JAMs play striking roles in cancer invasion and metastasis as discussed in the following chapter. The roles of JAMs in the epithelial and epidermis barrier have been concluded in Table 2.
TABLE 2
| Protein | Cell type | Partner | Final effect |
|---|---|---|---|
| JAM-A | Epidermis, intestinal epithelial cells, oral epithelial cells, prostate epithelial cells, and MDCK cells | Afadin and PDZ | Inhibits cell migration and induces permeability |
| Severson et al. (2009) | (Tang et al. (2021); | ||
| α3β1 integrin | Meng et al. (2019); | ||
| Thölmann et al. (2022) | Ye et al. (2011); | ||
| Naydenov et al. (2018)) | |||
| Reduces collective cell motility | |||
| (Thölmann et al. (2022)) | |||
| JAM-C | Human RPE cell | β1 integrin | Inhibits migration but not proliferation and decreases the permeability |
| Hou et al. (2012) | (Hou et al. (2012)) | ||
| JAML | Epithelial γδ T cell | CAR | Promotes proliferation, migration, and adhesion |
| Witherden et al. (2010) | (Witherden et al. (2010); | ||
| Verdino et al. (2011); | |||
| Johnson et al. (2021)) |
JAMs in the epithelial and epidermis barrier.
Endothelial and Endothelial Barrier
JAM-A regulates cell migration through changes in directional persistence under shear flow by cooperating with microtubule-stabilizing pathways in endothelial cells (ECs) (Huang et al., 2006; Severson and Parkos 2009a). Soluble JAM-A blocked cultured endothelial cells migration (Koenen et al., 2009). Signaling through JAM-A is necessary for alpha(v)beta(3)-dependent HUVEC migration, and this effect could be increased by engagement of the ligand-binding site of the integrin by Arg-Gly-Asp-Ser (RGDS) peptide and blocked by phosphoinositide 3-kinase and protein kinase C inhibitors (Naik and Naik 2006). The ternary JAM-A-CD9-αvβ3 integrin complex releases JAM-A upon bFGF stimulation to activate ERK and to regulate endothelial cell migration on vitronectin (Naik et al., 2003; Parise 2003; ; Peddibhotla et al., 2013). Similar to its role in the epithelium, JAM-A dimerization works in close cytoplasmic apposition of complexes containing specific PDZ domain-containing scaffold proteins, which activates small G protein Rap1 to stabilize β1 integrin protein and promotes endothelial cell migration (Severson and Parkos 2009b). Furthermore, N-glycosylation of JAM-A contributes to Rap1 activity, and glycosylation of N185 is required for JAM-A-mediated reduction of cell migration (Scott et al., 2015). ZO-1 and JAM-A assemble into a cooperative unit and then induce the formation of actin/myosin II stress fibers and redistribution of vinculin and PAK2 from adherens junction to focal adhesions in primary EC, regulating endothelial cell migration and angiogenic potential (Tornavaca et al., 2015). Tight junction protein (JAM-A and ZO-1) expression suppressed by rosiglitazone, which is linked to promote endothelial cell migration and induced permeability resulting from rosiglitazone (Ku et al., 2017). miR-145-rich exosomes can inhibit the migration of HUVECs via targeting JAM-A (Yang et al., 2021). The inhibitory effects on cell migration of human retinal capillary endothelial cells (HRCECs) induced by high concentrations of glucose were reversed once the expression of secreted protein acidic and rich in cysteine (SPARC) was inhibited, possibly associated with increased expression of JAM1 (). Incidentally, JAM-A is a prerequisite for inflamed SMCs migration ().
Consistently, soluble matrix-bound forms of JAM-C could be instrumental in guiding migration and adhesion of hematopoietic cells and vascular endothelial cells to the limbal niche, but further studies are warranted to investigate the precise role of JAMs and other IgCAMs in the human limbus (Polisetti et al., 2016). sJAM-C stimulates human microvascular endothelial cell (HMVEC) migration in vitro, dependent on Src, p38, and PI3K (Rabquer et al., 2010). The ubiquitylation of JAM-C by the E3 ligase Casitas B-lineage lymphoma (CBL) and dynamic JAM-C trafficking and degradation are necessary for junctional remodeling during cell migration (Kostelnik et al., 2019). Over-expressed or hypoxia-induced miR-212/132 led to a downregulation of JAM-C in human brain microvascular endothelial cells (BMECs) and resulted in slower migration of BMECs (). JAM-C, expressed by the tumor endothelium, is obligated to transvascular migration of embryonic-endothelial progenitor cells (e-EPCs) ().
To conclude, various types of endothelial cells migrate with the regulation of JAMs related to diverse diseases. JAMs mediate a variety of immune cells. Transendothelial migration is another predominant function, and this review will discuss it in the next chapter.
Immune Cells
JAMs governing various types of immune cell migration has been a project under the limelight, especially their function in transendothelial migration (TEM) and transepithelial migration (TEpM). The first and second immunoglobulin domains of JAM-A and the I domain of leukocyte function-associated antigen-1 (LFA-1) support the interaction of JAM-A snd LFA-1, which destabilizes the JAM-A homophilic interaction to promote LFA-1-dependent transendothelial migration of T cells and neutrophils (Ostermann et al., 2002; ; Wojcikiewicz et al., 2009). N-glycosylation of JAM-A turned out to regulate leukocyte LFA-1 binding (Scott et al., 2015). Furthermore, phosphorylation of JAM-A at Ser-284 activated RhoA to facilitate leukocyte TEM through interactions with the integrin LFA-1, dependent on PI3K-mediated activation of GEF-H1 and p115 RhoGEF (Scott et al., 2016). JAM-A antagonist peptide (JAM-Ap) blocked the interaction of JAM-A with LFA on neutrophils and monocytes/macrophages and attenuated brain ischemia/reperfusion (I/R)-induced neutrophil and monocyte infiltration into the brain parenchyma (Sladojevic et al., 2014). Meanwhile, pro-inflammatory cytokines such as TNF-alpha and IFN-gamma induced JAM redistribution and might further promote TEM of leukocytes (Ozaki et al., 1999). Apart from the typical partnership with LFA-1, JAMs instruct TEM through other mechanisms as follows:
Stem and Progenitor Cells
Wu et al. found that the JAM-A overexpression MSCs (JAM-A(ov) MSCs) migrated into the hair follicle (HF) sheath, and JAM-A promoted MSC proliferation and migration by activating T-cell lymphoma invasion and metastasis 1 (Tiam1) (Wu et al., 2014; Wu et al., 2015). Moreover, a JAM-C-blocking monoclonal antibody induces HSPC mobilization in a JAM-B dependent manner ().
Neutrophil (PMN)
JAM-A mediated neutrophil migration through the endothelium, which is dependent on IL-1β stimulus and only required endothelial-cell JAM-A and not leukocyte JAM-A (Woodfin et al., 2007; ). Furthermore, JAM-A mediates TNF-alpha-induced neutrophil transmigration by activating leukocytes and endothelial cells in vivo (Woodfin et al., 2009). JAM-A exclusively secreted from cardiac progenitor cells (CPCs) inhibited the transmigration across inflamed endothelium into the myocardium and affected complement factor 5 (C5aR)-dependent function, reducing oxidative stress and inflammatory response after infarction (Mueller et al., 2013; Liu et al., 2014). JAM-A activity promotes migration of PMNs into the alveolar space, also relevant to increased oxidative stress (Lakshmi et al., 2012). Vasodilator-stimulated phosphoprotein (VASP) is colocalized with ZO-1, occludin, and JAM-1 and may favor PMN transmigration (). Antihuman JAM mAbs and high-titer polyclonal mouse antiserum generated against recombinant JAM seem to show no functional effect on TEpM, TEpM in the reverse direction, and PMN transmigration across human microvascular endothelial cell monolayers (Liu et al., 2000). Khandoga et al. first identified JAM-A as an endothelial receptor of neutrophil transmigration (Khandoga et al., 2005). PMN infiltration elevated, and the recruitment of leukocytes enhanced in the colonic mucosa of Jam-A−/− mice (Laukoetter et al., 2007). In uterine, mucosal epithelial cells stimulated with LPS and palmatine downregulated expression of JAM1 and could therefore facilitate the TEpM of leukocytes residing in the endometrium, such as neutrophils and macrophages (Hui et al., 2020). Distinguishing from JAM-A, PECAM-1 mediates migration through the endothelial-cell basement membrane when leukocyte PECAM-1 and endothelial-cell PECAM-1 to the same extent regulated via upregulated integrins α6β1 (; Woodfin et al., 2007). The Parkos team discovered that PMN migration into the colonic lumen was reduced in Jam-A−/− mice and Villin-Cre; Jam-Afl/fl mice, along with reduced peritoneal PMN migration in Villin-Cre; and Jam-afl/fl mice (; Luissint et al., 2019; ).
JAM-C mAbs and JAM-C/Fc chimeras significantly inhibited neutrophil transmigration, connected with the specific binding of JAM-C to the leukocyte β2-integrin Mac-1 (αMβ2, CD11b/CD18) (Zen et al., 2004). Furthermore, LFA-1/Mac-1-JAM-C bonds can accelerate PMN crawling under high shear stress (Li G. C et al., 2018). Orlova et al. discovered that soluble JAM-C decreased leukocytes TEM and endothelial permeability by modulating VE-cadherin-mediated cell–cell contacts, working together with inhibition of Mac-1 (; Orlova et al., 2006). However, Sircar et al. reported that JAM-C had a minimal role in neutrophil transmigration under shear flow conditions in vitro (Sircar et al., 2007). PMN TEM plays a considerable role in various inflammatory diseases. Transgenic mice overexpressing JAM-C under the control of the endothelial-specific promotor Tie2 showed increased leukocyte adhesion and transmigration to inflammatory sites (). Soluble mouse JAM-C reduced neutrophil emigration in the mouse with acute thioglycollate-induced peritonitis and selectively reduced neutrophil infiltration into inflamed joints (; Palmer et al., 2007). Cold-inducible RNA-binding protein (CIRP) induces neutrophil reverse transendothelial migration (rTEM) in sepsis by increasing neutrophil elastase (NE) and decreasing JAM-C (Jin et al., 2019). Blockade of JAM-C reduced the aged pro-inflammatory neutrophils in sepsis-induced acute lung injury (ALI), and JAM-C downregulation may contribute to acute pancreatitis (AP)-associated ALI via promoting neutrophil rTEM (Wu et al., 2016; Hirano et al., 2018). NE local proteolytically cleaved EC JAM-C via Mac-1 and therefore drove the lipid chemoattractant leukotriene B4 (LTB4) causing loss of venular JAM-C and promoting neutrophil reverse transendothelial cell migration (rTEM) in vivo (). JAM-C was regarded as a negative regulator of rTEM under conditions of ischemia–reperfusion (I-R) and cisplatin-induced acute kidney injury (AKI) (Woodfin et al., 2011; ; Kim et al., 2017).
Zinc metalloproteases cleaved JAML from the neutrophil surface during PMN TEpM, and fusion proteins containing JAML and CAR extracellular domains and antibodies against JAML and CAR inhibited TEpM (Zen et al., 2005; Weber et al., 2014). Zen et al. proposed a revised model of PMN TEpM: sequential Mac-1-mediated binding to JAM-C at desmosomes when PMN cross the TJ, followed by JAML binding to CAR (Zen et al., 2005).
Monocytes and Macrophages
A JAM-A mAb, BV11, was able to block human monocyte migration across bEND-3 cell monolayers in vitro and in the skin inflammatory and meningitis model in vivo (Martìn-Padura et al., 1998; ; Williams et al., 1999). Nevertheless, both a monoclonal antibody and polyclonal rabbit IgG to JAM-A decreased slightly in monocyte transmigration (Liu et al., 2000; Schenkel et al., 2004). Activation of lung vascular endothelial ADAM17 and ADAM10 markedly promotes ectodomain shedding of JAM-A to enhance total leukocyte and neutrophil recruitment by LFA-1- and JAM-A-dependent mechanisms (Koenen et al., 2009; ). Meanwhile, matrix metalloproteinase (MMP) contributes to the HIV-induced decreased expression of JAM-A and occludin, associated with elevated TEM of HIV-infected monocytes across an in vitro model of the blood–brain barrier (BBB) (Huang et al., 2009). Except for those functions of metalloproteinase in the previous content, Williams et al. found that CD14+CD16+ monocytes selectively transmigrated across the BBB model due to increased JAM-A and ALCAM expression in HIV-infected individuals (Williams et al., 2013; Williams et al., 2015). HIV+ CD14+CD16+ ART-treated monocytes (mature monocytes infected with HIV and treated with ART) preferentially transmigrate across the BBB to CCL2, which was reduced and/or blocked by blocking antibodies against junctional proteins JAM-A significantly (León-Rivera et al., 2021). In addition, buprenorphine limits the chemokine (C–C motif) ligand 2 (CCL2)-mediated monocyte transmigration into the central nervous system (CNS), through decreasing the phosphorylation of the junctional protein JAM-A increase (). Also, this process probably links to CCL2-induced JAM-A redistribution via RhoA and Rho kinase (Stamatovic et al., 2012). JAM-1 is necessary for cellular interactions during β2-integrin-dependent leukocyte adhesion and transmigration on the inflammatory endothelium (). It was found earlier that monocyte arrest and transmigration attenuated on activated Jam-A−/−ApoE−/− versus Jam-A+/+ApoE−/− endothelial cells under flow conditions in vitro (Zernecke et al., 2006). Then, Schmitt et al. found an endothelium-specific deficiency in JAM-A reduced mononuclear cell recruitment into the arterial wall, whereas somatic deficiency in JAM-A revealed no significant effects, accompanying endothelial JAM-A increased by oxidized low-density lipoprotein (oxLDL) but repressed by microRNA (miR)-145 (Schmitt et al., 2014a; Schmitt et al., 2014b; Liu et al., 2015). Tantalizingly, recruitment of platelets and monocytes to the inflamed endothelium increased in the blood of platelet-specific (tr)JAM-A-deficiency ApoE−/− mice, benefitted from αIIbβ3 signaling and the GPIbα–αMβ2 axis (Karshovska et al., 2015; Zhao et al., 2017). Ginkgolide B decreased the expression of JAM-A and reduced monocyte transmigration in oxLDL-treated HUVECs, linked to the attenuation of Akt phosphorylation (Liu et al., 2015). Additionally, p-cresol-impaired leukocyte TEM is potentially attributable to reduced membrane expression of JAM-A (). Deep hypothermia and post-hypothermic rewarming regulate leukocyte–endothelial interaction and TEM, associated with JAM-A surface expression (; ).
Liver irradiation does not lead to recruitment of leukocytes into the parenchyma, possibly related to the radiation-induced increase of JAM-1gene expression in rat livers in vivo and in hepatocytes in vitro (Moriconi et al., 2009). By the way, soluble JAM-C increased motility in hepatic stellate cells (Hintermann et al., 2016). Morphine, methamphetamine (Meth), and morphine- and tat-treatment significantly increased JAM-2 expression, while gp120 alone and in combination with Meth significantly decreased JAM-2 expression (Mahajan et al., 2008a; Mahajan et al., 2008b). All those treatments enhanced the TEM of immunocompetent cells across the BBB. Furthermore, JAM-C Fc chimera inhibited macrophage transmigration across hRPE (Hou et al., 2012). Blocking JAM-C function or JAM-B/-C interaction increased monocyte reverse transmigration in the peritonitis model (). Consistently, monoclonal antibodies directed against JAM-C significantly blocked the influx of leukocytes in which cerulein-induced acute pancreatitis was assessed (Vonlaufen et al., 2006). Leukocyte transmigration was suppressed in Jam-C−/− mice and enhanced in mice overexpressing JAM-C in their ECs (Scheiermann et al., 2009). Similar to antibody blockade, overexpression or gene silencing of JAM-C in human endothelium exposed to flow elevated rates of monocyte reverse-transendothelial migration under inflammatory conditions in vitro (). Neutralizing antibodies against JAM-C enhanced U937 cell migration through the rheumatoid arthritis (RA) synovial tissue fibroblast monolayer (Rabquer et al., 2008). JAM-C is upregulated by oxLDL and may thereby mediate both leukocyte adhesion and leukocyte TEM (Keiper et al., 2005b). Consequently, blocking JAM-C can assist the emigration of atherogenic monocytes/macrophages in plaques. In addition, exosomal miR-146a-5p that transported into endothelial cells reduced monocyte TEM by binding to the 3’untranslated region (3′UTR) of JAM-C (Hu et al., 2020). Monocytic JAML regulated TEM and TEpM of monocyte-derived THP-1 cells probably via binding to CAR, and this interaction is controlled by phosphorylation of CAR (Guo et al., 2009; Morton et al., 2016). During relapsing–remitting MS (RRMS), JAML has homophilic interaction with the BBB endothelium and heterophilical binding to CAR on the choroidal epithelium forming the blood–CSF barrier, which encourages monocyte and CD8 T-cell migration into the CNS ().
Dendritic Cell
JAM-A deficiency selectively increased DCs random motility and transmigration across lymphatic endothelial cells in vitro and enhanced DC migration to lymph nodes in vivo (). H33, a monoclonal antibody against mouse JAM-C, improved the migration of DCs to sites of infection and in draining lymph nodes ().
Lymphocytes
Under inflammation of the vascular wall, JAM-A mediated lymphocyte recruitment to the endothelium and subsequent TEM, through redistribution of JAM-A receptors toward endothelial junctions (Jaczewska et al., 2014). JAM-1 knockdown of EC inhibited chemokine-dependent TEM of effector memory (EM) CD4+ T cells (Manes and Pober 2011). Under flow conditions, stromal cell-derived factor (SDF)-1alpha triggered transendothelial chemotaxis of activated T cells and arrest on cytokine-costimulated endothelium, which could be inhibited by soluble JAM-A.Fc (sJAM-A.Fc) (Ostermann et al., 2005). Blocking EZH2 or JAM-A reduced T-cell adhesion, migration, and extravasation, and EZH2 was involved in leukocyte adhesion and migration via upregulating JAM-A (Tsou et al., 2018). VE-JAM (JAM-B) was prominently expressed in HEV and distributed at interendothelial boundaries (Palmeri et al., 2000). The Engelhardt team discovered JAM-B, implicated in CD8 T-cell migration to the CNS, as one ligand for α4β1-integrin, but JAM-B deficiency does not affect T-cell transmigration across the BBB in vitro (Martin-Blondel et al., 2015; Tietz et al., 2018). JAM-2 promotes lymphocyte TEM (Johnson-Léger et al., 2002). Recombinant JAM-C binds to Mac-1 on BM-DCs (Zimmerli et al., 2009). Although JAM-C was upregulated in activated human T lymphocytes (Immenschuh et al., 2009), JAM-C-deficiency did not affect DC homing, T-cell activation, and DC migration to lymph nodes (Zimmerli et al., 2009). JAM-C potentially works in the final steps of trafficking and transmigration of antigen-specific autoaggressive T-cells to the islets of Langerhans (). Anti-JAM-C antibodies could reduce migration of normal and malignant JAM-C-expressing B cells to bone marrow, lymph nodes, and spleen, probably associated with blockage of adhesion to their ligand JAM-B (). Not only that, endothelial-cell-selective adhesion molecule (ESAM)-1, an endothelial TJ protein linked with the JAMs, was predicted to attend cell migrations through the sinus-lining cell layer (Pfeiffer et al., 2008).
Taken together, JAMs have been recognized as important players controlling leukocyte transendothelial migration. According to the notable functions of TEM in various physiological and pathological situations, JAMs play complicated and variable roles (Figure 1).
FIGURE 1
Representative interaction and signaling of JAMs. Abbreviation is attached at the end.
Cancer
A couple of reviews summarized the function of JAMs in cancer in recent years, and this review focused on their roles in cancer invasion and metastasis.
Naik et al. discovered JAM-A expression was downregulated as breast cancer disease progresses and thereupon enhanced cancer cell migration (Naik et al., 2008; Naik and Naik 2008). McSherry et al. observed that knockdown or functional antagonism of JAM-A drove breast cancer cell migration via activation of Rap1 GTPase and β1-integrin (McSherry et al., 2009; McSherry et al., 2011). In the murine 4T1 breast cancer model, administration of Tβ4 and TGF-β1 decreased the sJAM-A levels in murine blood, and a peptide derived from the sequence of the F11R/JAM-A protein, peptide 4D (P4D), blocked the TEM of breast cancer cells in the presence of TNF/IFN and Tβ4 (). In human breast cancer cell lines, JAM-A blocked the pro-migratory function of CD146 (Imbert et al., 2012) and connected a unique antihuman CD81 antibody (5A6), which effectively halts tumor cell invasion and migration (Vences-Catalán et al., 2021). MicroRNA-495 stimulated breast cancer cell migration by targeting JAM-A (). In the Rip1Tag2 tumor model, Jam-A−/− DCs had a higher rate of DC migration through the endothelium into the tumor than Jam-A+/+ DCs (Murakami et al., 2010). High JAM-A expression induces EMT of nasopharyngeal carcinoma (NPC) cells in vitro and in vivo via the PI3K/Akt pathway, and lncRNA P73 antisense RNA 1 T (TP73-AS1) could upregulate JAM-A expression (Tian et al., 2015; ). Histone deacetylases (HDACs) inhibitors downregulated p63-mediated JAM-A expression, suppressing the proliferation, migration, and invasiveness of human head and neck squamous cell carcinoma (HNSCC) (Kakiuchi et al., 2021). Aberrant expression of JAM-A regulated PVR/CD155 to exacerbate malignancy of uterine cervical adenocarcinoma (Murakami et al., 2021). JAM-A restoration suppressed anaplastic thyroid carcinoma (ATC) cell motility and TEM, related to the level of phosphorylation of p53 and GSK3 α/β proteins (Orlandella et al., 2019). In colorectal cancer (CRC), MIR21 upregulation caused JAM-A downregulation and then activated ERK, AKT, and ROCK pathways in promoting invasiveness and metastasis (Lampis et al., 2021). Furthermore, JAM-A expression declined in renal cancer (Gutwein et al., 2009), gastric cancer (Huang et al., 2014), and multiple myeloma (MM) (Solimando et al., 2018) and impaired these cancer cells migration and invasion. Incidentally, N-glycosylation controlled JAM-A’s effects on the migration of MDA-MB-231 cells (Scott et al., 2015).
Qi et al. reported quantum dots (QDs) or cell-penetrating magnetic nanoparticles-mediated JAM-2 knockdown facilitated inhibition of glioma cell migration, and JAM-2 gene targeted the Notch pathway and regulated cytoskeleton remodeling and migration associated protein gene expression (Qi et al., 2013; Qi et al., 2014). Over-expression of JAM-2 in RKO cells resulted in decreasing growth, migration, adhesion, and invasion by regulating the transcription of MMP-9. Negatively binding of miR-374b and JAM-2 inhibits cervical cancer (CC) cell proliferation, migration, and invasion (Li X et al., 2018). JAM-B secreted by cancer cells could promote progression and invasion in pancreatic cancer (PanCa) by upregulating the c-Src signal and related downstream proteins (Zhang et al., 2020).
JAM-C dephosphorylation at serine 281 increased KLN 205 cell adhesion and migration by activating β3 integrins and deactivating β1 integrins (Mandicourt et al., 2007). In Lewis lung carcinoma cells (LLC1s), treatment with a monoclonal antibody directed against JAM-C reduced the infiltration of macrophages into tumors (Lamagna et al., 2005). Palmitoylation of JAM-C supported the movement to TJs and inhibited A549 lung cancer cells migration (). JAM3 endorsed CRC cell viability, colony formation, and migration (Zhou et al., 2019). Some researchers from Geneva University Hospital recounted JAM-C function in several cancers. Anti-JAM-C antibodies reduced migration of normal and malignant JAM-C-expressing B cells to bone marrow, lymph nodes, and spleen by blocking adhesion of JAM-C-expressing B cells to ligand JAM-B () and impaired lymphoma B-cell homing to supportive lymphoid microenvironments by driving the MAPK signaling pathway (). JAM-C/B combination escalated glioma growth and invasion in vivo, linked to activated c-Src proto-oncogene (Tenan et al., 2010). The dimerization sites E66-K68 of JAM-C affected mouse lung squamous carcinoma KLN 205 cells migration (Garrido-Urbani et al., 2018). Moreover, circKIF4A promoted cell proliferation and migration in ovarian cancer by sponging miR-127 and upregulating JAM3 expression (Sheng et al., 2020). B16 melanoma cell metastasis to the lung was proved to decrease in Jam-C−/− mice and endothelial-specific JAM-C-deficient mice, and treatment with soluble JAM-C created a similar decrease (Langer et al., 2011). JAM-C also promoted HT1080 human fibrosarcoma metastasis (). However, JAM-3 was proved to suppress migration and promote apoptosis of renal carcinoma cells (Li G. C et al., 2018).
JAML promoted gastric cancer (GC) cell migration and proliferation partially via p38 signaling (). In DC-based cancer immunotherapy, the interaction of JAML and CAR acted a crucial role in the TEM of mouse bone marrow-derived DCs (BMDCs) and human monocyte-derived DCs (MoDCs) (Roh et al., 2018).
In fact, numerous articles depicted the significant function of JAMs in cancer notwithstanding, but there are still many questions. For instance, JAM-A diminished the SLM8 cells line TEM, but JAM-C enhances the A375 cell line TEM conversely (Ghislin et al., 2011). Hence, figuring out how JAMs function in different cancer requires further investigation. The roles of JAMs in cancers have been concluded in Table 3.
TABLE 3
| Protein | Cancer | Final effect |
|---|---|---|
| JAM-A | Breast cancer, anaplastic thyroid carcinoma, and colorectal cancer | Inhibits invasion and migration |
| Naik et al. (2008) | ||
| Naik and Naik (2008) | ||
| McSherry et al. (2009) | ||
| McSherry et al. (2011) | ||
| Imbert et al. (2012) | ||
| Vences-Catalán et al. (2021) | ||
| Orlandella et al. (2019) | ||
| Lampis et al. (2021) | ||
| Nasopharyngeal carcinoma, head and neck squamous cell carcinoma, uterine cervical adenocarcinoma, renal cancer, gastric cancer, and multiple myeloma | Induces proliferation, migration, and invasiveness | |
| Tian et al. (2015) | ||
| Kakiuchi et al. (2021) | ||
| Murakami et al. (2021) | ||
| Gutwein et al. (2009) | ||
| Huang et al. (2014) | ||
| Solimando et al. (2018) | ||
| JAM-B | Glioma and pancreatic cancer | Promotes progression and invasion |
| Qi et al. (2013) | ||
| Qi et al. (2014) | ||
| Zhang et al. (2020) | ||
| JAM-C | Ovarian cancer, melanoma, and fibrosarcoma metastasis | Promotes cell proliferation and migration |
| Sheng et al. (2020) | ||
| Langer et al. (2011) | ||
| Renal carcinoma | Suppresses migration | |
| Li N et al. (2018) | ||
| JAML | Gastric cancer | Promotes migration and proliferation |
JAMs in cancers.
Conclusion and Prospective
Multiple research studies implicated the principal suppressive effect of JAMs in cell migration with tight junctions. Related inhibitory action was presumably due to the conjunction with the ZO family of scaffolding proteins ZO-1 (), claudin, afadin (Keiper et al., 2005a; Hartmann et al., 2020; ), Par6 (Gliki et al., 2004), Par-3 (), and several integrins (Parise 2003; Naik et al., 2003; ; Peddibhotla et al., 2013; Zen et al., 2004; Karshovska et al., 2015; Zhao et al., 2017; Martin-Blondel et al., 2015; Tietz et al., 2018) (Figure 1). Direct downstream proteins included one integrin ligand such collagen I, collagen IV, and fibronectin ().
Another point that deserved discussion should be shear flow, which is important for the migration of endothelial cells as well as leukocytes. Under flow conditions, JAM-A deficiency increased protrusion extension in the direction of flow and enhanced downstream cellular displacement by cooperating with microtubule-stabilizing pathways in ECs (Huang et al., 2006). Whereas, JAM-A deficiency and soluble JAM-A.Fc attenuated monocyte and activated T cells arrest and transmigration (Ostermann et al., 2005; Zernecke et al., 2006). Under shear flow conditions, the antibody against JAM-C scarcely influenced neutrophil transmigration yet elevated rates of monocyte reverse-transendothelial migration in vitro (Sircar et al., 2007; ).
In addition to the cells described previously, there was a rare report in the central nervous system. For example, Pard3A-dependent JAM-C adhesion promotes germinal zone (GZ) exit OF neuronal cells (). Nevertheless, JAMs exhibited distinct even opposite functions in different physiological and pathological activities (Ghislin et al., 2011). Since JAMs exhibit unclear roles in one specific cell type, it is more difficult to define their roles under one physiological state or pathological condition. At present, soluble JAMs, the antibody against JAMs, and Jam-deficient mice were developed and were favorable to follow-up studies and potential application. These results remind us that further and detailed examination is necessary for explaining specific influences. Figure 2.
FIGURE 2
Statements
Author contributions
Author JW conceptualized and wrote the manuscript. She solely contributed to the submitted version of the article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations and Glossary
AJsadherens junctionsAKIacute kidney injuryALIneutrophil elastase, acute lung injuryAPacute pancreatitisATCanaplastic thyroid carcinomaBBBblood–brain barrierBGbioactive glassBMDCsbone marrow-derived DCsBMECbrain microvascular endothelial cellsBTBblood–testis barrierC5aRcomplement factor 5CBLCasitas B-lineage lymphomaCCcervical cancerCCL2(C–C motif) ligand 2CIRPcold-inducible RNA-binding proteinCIScarcinoma in situCNPC-type natriuretic peptideCNScentral nervous systemCPAcyproterone acetateCPCscardiac progenitor cellsCRCcolorectal cancerECsendothelial cellse-EPCsembryonic-endothelial progenitor cellsEMeffector memoryESectoplasmic specializationESAMendothelial-cell-selective adhesion moleculeGCgastric cancerGCsgerm cellsGZgerminal zoneHDACshistone deacetylasesHFhair follicleHMVEChuman microvascular endothelial cellHNSCChead and neck squamous cell carcinomaHRCECshuman retinal capillary endothelial cellsI-Rischemia–reperfusionJAMsjunctional adhesion moleculesJAM-A(ov) MSCsJAM-A overexpression MSCsJAM-ApJAM-A antagonist peptideLFA-1leukocyte function-associated antigen-1LLC1Lewis lung carcinoma cellsLTB4leukotriene B4MCCsmulticiliated cellsMethmethamphetamineMMmultiple myelomaMMPmatrix metalloproteinaseMoDCsmonocyte-derived DCsNACN-acetyl-l-cysteineNPCnasopharyngeal carcinomaNRSFneuron-restrictive silencer factoroxLDLoxidized low-density lipoproteinPanCapancreatic cancerP4Dpeptide 4DP-gp, MDR1P-glycoproteinpSp1proximal Sp1QDsquantum dotsRArheumatoid arthritisRGDSArg-Gly-Asp-SerRPEretinal pigment epithelialRRMSrelapsing–remitting MSrTEMreverse transendothelial migrationSCsSertoli cellsSDFstromal cell-derived factorsJAM-A.Fcsoluble JAM-A.FcSmadmothers against decapentaplegicSPARCsecreted protein acidic and rich in cysteineTEMtransendothelial migrationTEpMtransepithelial migrationTGIFTG-interacting factorTiam1T-cell lymphoma invasion and metastasis 1TJstight junctionsTP73-AS1lncRNA P73 antisense RNA 1 T3′UTR3’untranslated regionVASPvasodilator-stimulated phosphoprotein
References
1
AlvarezJ. I.KébirH.CheslowL.ChabaratiM.LarochelleC.PratA. (2015). JAML Mediates Monocyte and CD8 T Cell Migration across the Brain Endothelium. Ann. Clin. Transl Neurol.2 (11), 1032–1037. 10.1002/acn3.255
2
AramsangtienchaiP.SpiegelmanN. A.CaoJ.LinH. (2017). S-palmitoylation of Junctional Adhesion Molecule C Regulates its Tight Junction Localization and Cell Migration. J. Biol. Chem.292 (13), 5325–5334. 10.1074/jbc.M116.730523
3
AravindanR. G.FominV. P.NaikU. P.ModelskiM. J.NaikM. U.GalileoD. S.et al (2012). CASK Interacts with PMCA4b and JAM-A on the Mouse Sperm Flagellum to Regulate Ca2+ Homeostasis and Motility. J. Cel. Physiol.227 (8), 3138–3150. 10.1002/jcp.24000
4
ArcangeliM.-L.BardinF.FronteraV.BidautG.ObradosE.AdamsR. H.et al (2014). Function of Jam-B/Jam-C Interaction in Homing and Mobilization of Human and Mouse Hematopoietic Stem and Progenitor Cells. Stem Cells32 (4), 1043–1054. 10.1002/stem.1624
5
Aurrand-LionsM.LamagnaC.DangerfieldJ. P.WangS.HerreraP.NoursharghS.et al (2005). Junctional Adhesion Molecule-C Regulates the Early Influx of Leukocytes into Tissues during Inflammation. J. Immunol.174 (10), 6406–6415. 10.4049/jimmunol.174.10.6406
6
AzariB. M.MarmurJ. D.SalifuM. O.CavusogluE.EhrlichY. H.KorneckiE.et al (2010). Silencing of the F11R Gene Reveals a Role for F11R/JAM-A in the Migration of Inflamed Vascular Smooth Muscle Cells and in Atherosclerosis. Atherosclerosis212 (1), 197–205. 10.1016/j.atherosclerosis.2010.05.014
7
BalletR.EmreY.JemelinS.CharmoyM.Tacchini-CottierF.ImhofB. A. (2014). Blocking Junctional Adhesion Molecule C Enhances Dendritic Cell Migration and Boosts the Immune Responses against Leishmania Major. Plos Pathog.10 (12), e1004550. 10.1371/journal.ppat.1004550
8
BednarekR.SelmiA.WojkowskaD.KarolczakK.PopielarskiM.StasiakM.et al (2020). Functional Inhibition of F11 Receptor (F11R/junctional Adhesion molecule-A/JAM-A) Activity by a F11R-Derived Peptide in Breast Cancer and its Microenvironment. Breast Cancer Res. Treat.179 (2), 325–335. 10.1007/s10549-019-05471-x
9
BoernerK.LuissintA.-C.ParkosC. A. (2021). Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice Using a Standardized Intestinal Loop Model. JoVE168. 10.3791/62093
10
BogertN. V.WernerI.KornbergerA.MeybohmP.MoritzA.KellerT.et al (2016). Influence of Hypothermia and Subsequent Rewarming upon Leukocyte-Endothelial Interactions and Expression of Junctional-Adhesion-Molecules A and B. Sci. Rep.6, 21996. 10.1038/srep21996
11
BogertN. V.WernerI.KornbergerA.VahlC.-F.Beiras-FernandezA. (2020). Effect of Rewarming on Leukocyte-Endothelial Interaction after Deep Hypothermic Preservation. Ann. Transpl.25, e919540. 10.12659/aot.919540
12
BradfieldP. F.MenonA.Miljkovic-LicinaM.LeeB. P.FischerN.FishR. J.et al (2016). Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques. PLoS One11 (7), e0159679. 10.1371/journal.pone.0159679
13
BradfieldP. F.ScheiermannC.NoursharghS.OdyC.LuscinskasF. W.RaingerG. E.et al (2007). JAM-C Regulates Unidirectional Monocyte Transendothelial Migration in Inflammation. Blood110 (7), 2545–2555. 10.1182/blood-2007-03-078733
14
BurekM.KönigA.LangM.FiedlerJ.OerterS.RoewerN.et al (2019). Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells. Transl. Stroke Res.10 (6), 672–683. 10.1007/s12975-018-0683-2
15
ByersS.GrahamR.DaiH. N.HoxterB. (1991). Development of Sertoli Cell Junctional Specializations and the Distribution of the tight-junction-associated Protein ZO-1 in the Mouse Testis. Am. J. Anat.191 (1), 35–47. 10.1002/aja.1001910104
16
CaoM.NieW.LiJ.ZhangY.YanX.GuanX.et al (2014). MicroRNA-495 Induces Breast Cancer Cell Migration by Targeting JAM-A. Protein Cell5 (11), 862–872. 10.1007/s13238-014-0088-2
17
Cartier-MichaudA.BaillyA.-L.BetziS.ShiX.LissitzkyJ.-C.ZarubicaA.et al (2017). Genetic, Structural, and Chemical Insights into the Dual Function of GRASP55 in Germ Cell Golgi Remodeling and JAM-C Polarized Localization during Spermatogenesis. Plos Genet.13 (6), e1006803. 10.1371/journal.pgen.1006803
18
CarvalloL.LopezL.CheF.-Y.LimJ.EugeninE. A.WilliamsD. W.et al (2015). Buprenorphine Decreases the CCL2-Mediated Chemotactic Response of Monocytes. J.I.194 (7), 3246–3258. 10.4049/jimmunol.1302647
19
CeraM. R.Del PreteA.VecchiA.CoradaM.Martin-PaduraI.MotoikeT.et al (2004). Increased DC Trafficking to Lymph Nodes and Contact Hypersensitivity in Junctional Adhesion Molecule-A-Deficient Mice. J. Clin. Invest.114 (5), 729–738. 10.1172/jci21231
20
CeraM. R.FabbriM.MolendiniC.CoradaM.OrsenigoF.RehbergM.et al (2009). JAM-A Promotes Neutrophil Chemotaxis by Controlling Integrin Internalization and Recycling. J. Cel Sci122 (Pt 2), 268–277. 10.1242/jcs.037127
21
ChakrabortyA.SinghV.SinghK.RajenderS. (2020). Excess Iodine Impairs Spermatogenesis by Inducing Oxidative Stress and Perturbing the Blood Testis Barrier. Reprod. Toxicol.96, 128–140. 10.1016/j.reprotox.2020.06.012
22
ChalmersA. D.WhitleyP. (2012). Continuous Endocytic Recycling of Tight junction Proteins: How and Why?Essays Biochem.53, 41–54. 10.1042/bse0530041
23
ChavakisT.PreissnerK. T.SantosoS. (2003). Leukocyte Trans-endothelial Migration: JAMs Add New Pieces to the Puzzle. Thromb. Haemost.89 (1), 13–17.
24
ChavakisT.KeiperT.Matz-WestphalR.HersemeyerK.SachsU. J.NawrothP. P.et al (2004). The Junctional Adhesion Molecule-C Promotes Neutrophil Transendothelial Migration In Vitro and In Vivo. J. Biol. Chem.279 (53), 55602–55608. 10.1074/jbc.M404676200
25
ChoW.SongJ.-Y.OhS. W.KimM. G.KoY. S.LeeH. Y.et al (2017). Fate of Neutrophils during the Recovery Phase of Ischemia/Reperfusion Induced Acute Kidney Injury. J. Korean Med. Sci.32 (10), 1616–1625. 10.3346/jkms.2017.32.10.1616
26
ChoiY. S.KimY. C.JiS.ChoiY. (2014). Increased Bacterial Invasion and Differential Expression of Tight-junction Proteins, Growth Factors, and Growth Factor Receptors in Periodontal Lesions. J. Periodontol.85 (8), e313–e322. 10.1902/jop.2014.130740
27
ChristenS.CoppietersK.RoseK.HoldenerM.BayerM.PfeilschifterJ. M.et al (2013). Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice. PLoS One8 (1), e54675. 10.1371/journal.pone.0054675
28
ColomB.BodkinJ. V.BeyrauM.WoodfinA.OdyC.RourkeC.et al (2015). Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo. Immunity42 (6), 1075–1086. 10.1016/j.immuni.2015.05.010
29
ComerfordK. M.LawrenceD. W.SynnestvedtK.LeviB. P.ColganS. P. (2002). Role of Vasodilator‐stimulated Phosphoprotein in Protein Kinase A‐induced Changes in Endothelial Junctional Permeability. FASEB j.16 (6), 583–585. 10.1096/fj.01-0739fje
30
CookeV. G.NaikM. U.NaikU. P. (2006). Fibroblast Growth Factor-2 Failed to Induce Angiogenesis in Junctional Adhesion Molecule-A-Deficient Mice. Atvb26 (9), 2005–2011. 10.1161/01.Atv.0000234923.79173.99
31
CzabankaM.PetrilliL. L.Elvers-HornungS.BiebackK.Albert ImhofB.VajkoczyP.et al (2020). Junctional Adhesion Molecule-C Mediates the Recruitment of Embryonic-Endothelial Progenitor Cells to the Perivascular Niche during Tumor Angiogenesis. Ijms21 (4), 1209. 10.3390/ijms21041209
32
DaiB. Q.JiangX.FengL. C. (2021). LncRNA TP73‐AS1 Regulates miR ‐495 Expression to Promote Migration and Invasion of Nasopharyngeal Carcinoma Cells through Junctional Adhesion Molecule A. Kaohsiung J. Med. Sci.37 (5), 361–370. 10.1002/kjm2.12338
33
DangerfieldJ.LarbiK. Y.HuangM.-T.DewarA.NoursharghS. (2002). PECAM-1 (CD31) Homophilic Interaction Up-Regulates α6β1 on Transmigrated Neutrophils In Vivo and Plays a Functional Role in the Ability of α6 Integrins to Mediate Leukocyte Migration through the Perivascular Basement Membrane. J. Exp. Med.196 (9), 1201–1212. 10.1084/jem.20020324
34
DanieleL. L.AdamsR. H.DuranteD. E.PughE. N.PhilpN. J. (2007). Novel Distribution of Junctional Adhesion Molecule-C in the Neural Retina and Retinal Pigment Epithelium. J. Comp. Neurol.505 (2), 166–176. 10.1002/cne.21489
35
Del MaschioA.De LuigiA.Martin-PaduraI.BrockhausM.BartfaiT.FruscellaP.et al (1999). Leukocyte Recruitment in the Cerebrospinal Fluid of Mice with Experimental Meningitis Is Inhibited by an Antibody to Junctional Adhesion Molecule (JAM). J. Exp. Med.190 (9), 1351–1356. 10.1084/jem.190.9.1351
36
DoñateC.OdyC.McKeeT.Ruault-JungblutS.FischerN.RoprazP.et al (2013). Homing of Human B Cells to Lymphoid Organs and B-Cell Lymphoma Engraftment Are Controlled by Cell Adhesion Molecule JAM-C. Cancer Res.73 (2), 640–651. 10.1158/0008-5472.Can-12-1756
37
DoñateC.Vijaya KumarA.ImhofB. A.MatthesT. (2016). Anti-JAM-C Therapy Eliminates Tumor Engraftment in a Xenograft Model of Mantle Cell Lymphoma. J. Leukoc. Biol.100 (5), 843–853. 10.1189/jlb.1HI1114-549RR
38
DreymuellerD.MartinC.KogelT.PruessmeyerJ.HessF. M.HoriuchiK.et al (2012). Lung Endothelial ADAM17 Regulates the Acute Inflammatory Response to Lipopolysaccharide. EMBO Mol. Med.4 (5), 412–423. 10.1002/emmm.201200217
39
EbnetK. (2017). Junctional Adhesion Molecules (JAMs): Cell Adhesion Receptors with Pleiotropic Functions in Cell Physiology and Development. Physiol. Rev.97 (4), 1529–1554. 10.1152/physrev.00004.2017
40
EbnetK.SuzukiA.OhnoS.VestweberD. (2004). Junctional Adhesion Molecules (JAMs): More Molecules with Dual Functions?J. Cel Sci117 (Pt 1), 19–29. 10.1242/jcs.00930
41
EconomopoulouM.HammerJ.WangF.FarissR.MaminishkisA.MillerS. S. (2009). Expression, Localization, and Function of Junctional Adhesion Molecule-C (JAM-C) in Human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci.50 (3), 1454–1463. 10.1167/iovs.08-2129
42
FamulskiJ. K.TrivediN.HowellD.YangY.TongY.GilbertsonR.et al (2010). Siah Regulation of Pard3A Controls Neuronal Cell Adhesion during Germinal Zone Exit. Science330 (6012), 1834–1838. 10.1126/science.1198480
43
FangY.YangJ.ZuG.CongC.LiuS.XueF.et al (2021). Junctional Adhesion Molecule-like Protein Promotes Tumor Progression and Metastasis via P38 Signaling Pathway in Gastric Cancer. Front. Oncol.11, 565676. 10.3389/fonc.2021.565676
44
FaureV.CeriniC.PaulP.BerlandY.Dignat-GeorgeF.BrunetP. (2006). The Uremic Solute P-Cresol Decreases Leukocyte Transendothelial Migration In Vitro. Int. Immunol.18 (10), 1453–1459. 10.1093/intimm/dxl077
45
FlemmingS.LuissintA.-C.NusratA.ParkosC. A. (2018). Analysis of Leukocyte Transepithelial Migration Using an In Vivo Murine Colonic Loop Model. JCI insight3 (20). 10.1172/jci.insight.99722
46
FraemohsL.KoenenR. R.OstermannG.HeinemannB.WeberC. (2004). The Functional Interaction of the β2 Integrin Lymphocyte Function-Associated Antigen-1 with Junctional Adhesion Molecule-A Is Mediated by the I Domain. J. Immunol.173 (10), 6259–6264. 10.4049/jimmunol.173.10.6259
47
FuY.TangM.XiangX.LiuK.XuX. (2019). Glucose Affects Cell Viability, Migration, Angiogenesis and Cellular Adhesion of Human Retinal Capillary Endothelial Cells via SPARC. Exp. Ther. Med.17 (1), 273–283. 10.3892/etm.2018.6970
48
FujitaE.TanabeY.HiroseT.Aurrand-LionsM.KasaharaT.ImhofB. A.et al (2007). Loss of Partitioning-defective-3/isotype-specific Interacting Protein (par-3/ASIP) in the Elongating Spermatid of RA175 (IGSF4A/SynCAM)-Deficient Mice. Am. J. Pathol.171 (6), 1800–1810. 10.2353/ajpath.2007.070261
49
FuseC.IshidaY.HikitaT.AsaiT.OkuN. (2007). Junctional Adhesion Molecule-C Promotes Metastatic Potential of HT1080 Human Fibrosarcoma. J. Biol. Chem.282 (11), 8276–8283. 10.1074/jbc.M608836200
50
GarciaM. A.NelsonW. J.ChavezN. (2018). Cell-Cell Junctions Organize Structural and Signaling Networks. Cold Spring Harb Perspect. Biol.10 (4), a029181. 10.1101/cshperspect.a029181
51
Garrido-UrbaniS.BradfieldP. F.ImhofB. A. (2014). Tight junction Dynamics: the Role of Junctional Adhesion Molecules (JAMs). Cell Tissue Res355 (3), 701–715. 10.1007/s00441-014-1820-1
52
Garrido-UrbaniS.VonlaufenA.StalinJ.De GrandisM.RoprazP.JemelinS.et al (2018). Junctional Adhesion Molecule C (JAM-C) Dimerization Aids Cancer Cell Migration and Metastasis. Biochim. Biophys. Acta (Bba) - Mol. Cel Res.1865 (4), 638–649. 10.1016/j.bbamcr.2018.01.008
53
GhislinS.ObinoD.MiddendorpS.BoggettoN.Alcaide-LoridanC.DeshayesF. (2011). Junctional Adhesion Molecules Are Required for Melanoma Cell Lines Transendothelial Migration In Vitro. Pigment Cel Melanoma Res24 (3), 504–511. 10.1111/j.1755-148X.2011.00856.x
54
GlikiG.EbnetK.Aurrand-LionsM.ImhofB. A.AdamsR. H. (2004). Spermatid Differentiation Requires the Assembly of a Cell Polarity Complex Downstream of Junctional Adhesion Molecule-C. Nature431 (7006), 320–324. 10.1038/nature02877
55
GrimaldiC.RazE. (2020). Germ Cell Migration-Evolutionary Issues and Current Understanding. Semin. Cel Develop. Biol.100, 152–159. 10.1016/j.semcdb.2019.11.015
56
GuoY.-L.BaiR.ChenC. X.-J.LiuD.-Q.LiuY.ZhangC.-Y.et al (2009). Role of Junctional Adhesion Molecule-like Protein in Mediating Monocyte Transendothelial Migration. Atvb29 (1), 75–83. 10.1161/atvbaha.108.177717
57
GutweinP.SchrammeA.VossB.Abdel-BakkyM. S.DobersteinK.LudwigA.et al (2009). Downregulation of Junctional Adhesion Molecule-A Is Involved in the Progression of clear Cell Renal Cell Carcinoma. Biochem. Biophysical Res. Commun.380 (2), 387–391. 10.1016/j.bbrc.2009.01.100
58
HartmannC.SchwietzerY. A.OtaniT.FuruseM.EbnetK. (2020). Physiological Functions of Junctional Adhesion Molecules (JAMs) in Tight Junctions. Biochim. Biophys. Acta (Bba) - Biomembranes1862 (9), 183299. 10.1016/j.bbamem.2020.183299
59
HintermannE.BayerM.EhserJ.Aurrand-LionsM.PfeilschifterJ. M.ImhofB. A.et al (2016). Murine Junctional Adhesion Molecules JAM-B and JAM-C Mediate Endothelial and Stellate Cell Interactions during Hepatic Fibrosis. Cell Adhes. Migration10 (4), 419–433. 10.1080/19336918.2016.1178448
60
HiranoY.OdeY.OchaniM.WangP.AzizM. (2018). Targeting Junctional Adhesion molecule‐C Ameliorates Sepsis‐induced Acute Lung Injury by Decreasing CXCR4+aged Neutrophils. J. Leukoc. Biol.104 (6), 1159–1171. 10.1002/jlb.3a0218-050r
61
HoltJ. R.ZengW.-Z.EvansE. L.WooS.-H.MaS.AbuwardaH.et al (2021). Spatiotemporal Dynamics of PIEZO1 Localization Controls Keratinocyte Migration during Wound Healing. eLife10. 10.7554/eLife.65415
62
HouX.HuD.WangY.-s.TangZ.-s.ZhangF.ChavakisT.et al (2012). Targeting of Junctional Adhesion Molecule-C Inhibits Experimental Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci.53 (3), 1584–1591. 10.1167/iovs.11-9005
63
HuW.XuB.ZhangJ.KouC.LiuJ.WangQ.et al (2020). Exosomal miR-146a-5p from Treponema Pallidum-Stimulated Macrophages Reduces Endothelial Cells Permeability and Monocyte Transendothelial Migration by Targeting JAM-C. Exp. Cel Res.388 (1), 111823. 10.1016/j.yexcr.2020.111823
64
HuangH.CruzF.BazzoniG. (2006). Junctional Adhesion Molecule-A Regulates Cell Migration and Resistance to Shear Stress. J. Cel. Physiol.209 (1), 122–130. 10.1002/jcp.20712
65
HuangJ.-y.XuY.-y.SunZ.WangZ.-n.ZhuZ.SongY.-x.et al (2014). Low Junctional Adhesion Molecule A Expression Correlates with Poor Prognosis in Gastric Cancer. J. Surg. Res.192 (2), 494–502. 10.1016/j.jss.2014.06.025
66
HuangW.EumS. Y.AndrásI. E.HennigB.ToborekM. (2009). PPARα and PPARγ Attenuate HIV‐induced Dysrégulation of Tight junction Proteins by Modulations of Matrix Metalloproteinase and Proteasome Activities. FASEB j.23 (5), 1596–1606. 10.1096/fj.08-121624
67
HuiW.FengY.BaoqiY.ShuweiD.RuihuaX.JiongjieH.et al (2020). Comparative Proteomics Analysis Indicates that Palmatine Contributes to Transepithelial Migration by Regulating Cellular Adhesion. Pharm. Biol.58 (1), 646–654. 10.1080/13880209.2020.1784961
68
ImbertA.-M.GarulliC.ChoquetE.KoubiM.Aurrand-LionsM.ChabannonC. (2012). CD146 Expression in Human Breast Cancer Cell Lines Induces Phenotypic and Functional Changes Observed in Epithelial to Mesenchymal Transition. PLoS One7 (8), e43752. 10.1371/journal.pone.0043752
69
ImmenschuhS.NaiduS.ChavakisT.BeschmannH.LudwigR. J.SantosoS. (2009). Transcriptional Induction of Junctional Adhesion Molecule-C Gene Expression in Activated T Cells. J. Leukoc. Biol.85 (5), 796–803. 10.1189/jlb.0708422
70
JaczewskaJ.AbdulredaM. H.YauC. Y.SchmittM. M.SchubertI.BerggrenP.-O.et al (2014). TNF-α and IFN-γ Promote Lymphocyte Adhesion to Endothelial Junctional Regions Facilitating Transendothelial Migration. J. Leukoc. Biol.95 (2), 265–274. 10.1189/jlb.0412205
71
JiaX.XuY.WuW.FanY.WangG.ZhangT.et al (2017). Aroclor1254 Disrupts the Blood-Testis Barrier by Promoting Endocytosis and Degradation of junction Proteins via P38 MAPK Pathway. Cell Death Dis8 (5), e2823. 10.1038/cddis.2017.224
72
JinH.AzizM.OdeY.WangP. (2019). CIRP Induces Neutrophil Reverse Transendothelial Migration in Sepsis. Shock51 (5), 548–556. 10.1097/shk.0000000000001257
73
JohnsonM. D.OtukiM. F.CabriniD. A.RudolphR.WitherdenD. A.HavranW. L. (2021). Hspa8 and ICAM‐1 as Damage‐induced Mediators of γδ T Cell Activation. J. Leukoc. Bio111, 135–145. 10.1002/jlb.3ab0420-282r
74
Johnson-LégerC. A.Aurrand-LionsM.BeltraminelliN.FaselN.ImhofB. A. (2002). Junctional Adhesion Molecule-2 (JAM-2) Promotes Lymphocyte Transendothelial Migration. Blood100 (7), 2479–2486. 10.1182/blood-2001-11-0098
75
KakiuchiA.KakukiT.OhwadaK.KuroseM.KondohA.ObataK.et al (2021). HDAC Inhibitors Suppress the Proliferation, Migration and Invasiveness of Human Head and Neck Squamous Cell Carcinoma Cells via P63-mediated T-ight junction M-olecules and P-21-mediated G-rowth A-rrest. Oncol. Rep.45 (4). 10.3892/or.2021.7997
76
KanamoriM.OikawaK.TanemuraK.HaraK. (2019). Mammalian Germ Cell Migration during Development, Growth, and Homeostasis. Reprod. Med. Biol.18 (3), 247–255. 10.1002/rmb2.12283
77
KangL. I.WangY.SuckowA. T.CzymmekK. J.CookeV. G.NaikU. P.et al (2007). Deletion of JAM-A Causes Morphological Defects in the Corneal Epithelium. Int. J. Biochem. Cel Biol.39 (3), 576–585. 10.1016/j.biocel.2006.10.016
78
KarshovskaE.ZhaoZ.BlanchetX.SchmittM. M. N.BidzhekovK.SoehnleinO.et al (2015). Hyperreactivity of Junctional Adhesion Molecule A-Deficient Platelets Accelerates Atherosclerosis in Hyperlipidemic Mice. Circ. Res.116 (4), 587–599. 10.1161/circresaha.116.304035
79
KawauchiT. (2012). Cell Adhesion and its Endocytic Regulation in Cell Migration during Neural Development and Cancer Metastasis. Ijms13 (4), 4564–4590. 10.3390/ijms13044564
80
KeiperT.SantosoS.NawrothP. P.OrlovaV.ChavakisT. (2005a). The Role of Junctional Adhesion Molecules in Cell-Cell Interactions. Histol. Histopathol20 (1), 197–203. 10.14670/hh-20.197
81
KeiperT.Al‐FakhriN.ChavakisE.AthanasopoulosA. N.IsermannB.HerzogS.et al (2005b). The Role of Junctional Adhesion molecule‐C (JAM‐C) in Oxidized LDL‐mediated Leukocyte Recruitment. FASEB j.19 (14), 2078–2080. 10.1096/fj.05-4196fje
82
KhandogaA.KesslerJ. S.MeissnerH.HanschenM.CoradaM.MotoikeT.et al (2005). Junctional Adhesion Molecule-A Deficiency Increases Hepatic Ischemia-Reperfusion Injury Despite Reduction of Neutrophil Transendothelial Migration. Blood106 (2), 725–733. 10.1182/blood-2004-11-4416
83
KimS. C.KoY. S.LeeH. Y.KimM.-G.JoS.-K.ChoW.-Y. (2017). Blocking Junctional Adhesion Molecule C Promotes the Recovery of Cisplatin-Induced Acute Kidney Injury. Korean J. Intern. Med.32 (6), 1053–1061. 10.3904/kjim.2016.060
84
KoenenR. R.PruessmeyerJ.SoehnleinO.FraemohsL.ZerneckeA.SchwarzN.et al (2009). Regulated Release and Functional Modulation of Junctional Adhesion Molecule A by Disintegrin Metalloproteinases. Blood113 (19), 4799–4809. 10.1182/blood-2008-04-152330
85
KostelnikK. B.BarkerA.SchultzC.MitchellT. P.RajeeveV.WhiteI. J.et al (2019). Dynamic Trafficking and Turnover of JAM-C Is Essential for Endothelial Cell Migration. Plos Biol.17 (12), e3000554. 10.1371/journal.pbio.3000554
86
KuY. H.ChoB.-J.KimM. J.LimS.ParkY. J.JangH. C.et al (2017). Rosiglitazone Increases Endothelial Cell Migration and Vascular Permeability through Akt Phosphorylation. BMC Pharmacol. Toxicol.18 (1), 62. 10.1186/s40360-017-0169-y
87
LakshmiS. P.ReddyA. T.NaikM. U.NaikU. P.ReddyR. C. (2012). Effects of JAM-A Deficiency or Blocking Antibodies on Neutrophil Migration and Lung Injury in a Murine Model of ALI. Am. J. Physiology-Lung Cell Mol. Physiol.303 (9), L758–L766. 10.1152/ajplung.00107.2012
88
LamagnaC.Hodivala-DilkeK. M.ImhofB. A.Aurrand-LionsM. (2005). Antibody against Junctional Adhesion Molecule-C Inhibits Angiogenesis and Tumor Growth. Cancer Res.65 (13), 5703–5710. 10.1158/0008-5472.Can-04-4012
89
LampisA.HahneJ. C.GaspariniP.CascioneL.HedayatS.VlachogiannisG.et al (2021). MIR21-induced Loss of Junctional Adhesion Molecule A Promotes Activation of Oncogenic Pathways, Progression and Metastasis in Colorectal Cancer. Cell Death Differ28 (10), 2970–2982. 10.1038/s41418-021-00820-0
90
LangerH. F.OrlovaV. V.XieC.KaulS.SchneiderD.LonsdorfA. S.et al (2011). A Novel Function of Junctional Adhesion Molecule-C in Mediating Melanoma Cell Metastasis. Cancer Res.71 (12), 4096–4105. 10.1158/0008-5472.Can-10-2794
91
LaukoetterM. G.NavaP.LeeW. Y.SeversonE. A.CapaldoC. T.BabbinB. A.et al (2007). JAM-A Regulates Permeability and Inflammation in the Intestine In Vivo. J. Exp. Med.204 (13), 3067–3076. 10.1084/jem.20071416
92
León-RiveraR.VeenstraM.DonosoM.TellE.EugeninE. A.MorgelloS.et al (2021). Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies to Reduce CNS Viral Reservoirs in the cART Era. mBio12 (2). 10.1128/mBio.03633-20
93
LiG. C.CaoX. Y.LiY. N.QiuY. Y.LiY. N.LiuX. J.et al (2018). MicroRNA‐374b Inhibits Cervical Cancer Cell Proliferation and Induces Apoptosis through the P38/ERK Signaling Pathway by Binding to JAM‐2. J. Cel Physiol233 (9), 7379–7390. 10.1002/jcp.26574
94
Li NN.YangH.WangM.LüS.ZhangY.LongM. (2018). Ligand-specific Binding Forces of LFA-1 and Mac-1 in Neutrophil Adhesion and Crawling. MBoC29 (4), 408–418. 10.1091/mbc.E16-12-0827
95
LiX.YinA.ZhangW.ZhaoF.LvJ.LvJ.et al (2018). Jam3 Promotes Migration and Suppresses Apoptosis of Renal Carcinoma Cell Lines. Int. J. Mol. Med.42 (5), 2923–2929. 10.3892/ijmm.2018.3854
96
LiuM. L.NagaiT.TokunagaM.IwanagaK.MatsuuraK.TakahashiT.et al (2014). Anti‐Inflammatory Peptides from Cardiac Progenitors Ameliorate Dysfunction after Myocardial Infarction. Jaha3 (6), e001101. 10.1161/jaha.114.001101
97
LiuX.SunW.ZhaoY.ChenB.WuW.BaoL.et al (20152015). Ginkgolide B Inhibits JAM-A, Cx43, and VE-Cadherin Expression and Reduces Monocyte Transmigration in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells. Oxidative Med. Cell Longevity2015, 1–10. 10.1155/2015/907926
98
LiuY.NusratA.SchnellF. J.ReavesT. A.WalshS.PochetM.et al (2000). Human junction Adhesion Molecule Regulates Tight junction Resealing in Epithelia. J. Cel Sci113 ( Pt 13) (Pt 13), 2363–2374. 10.1242/jcs.113.13.2363
99
LuissintA.-C.NusratA.ParkosC. A. (2014). JAM-related Proteins in Mucosal Homeostasis and Inflammation. Semin. Immunopathol36 (2), 211–226. 10.1007/s00281-014-0421-0
100
LuissintA.-C.WilliamsH. C.KimW.FlemmingS.AzcutiaV.HilgarthR. S.et al (2019). Macrophage-dependent Neutrophil Recruitment Is Impaired under Conditions of Increased Intestinal Permeability in JAM-A-Deficient Mice. Mucosal Immunol.12 (3), 668–678. 10.1038/s41385-019-0143-7
101
MahajanS. D.AalinkeelR.SykesD. E.ReynoldsJ. L.BindukumarB.AdalA.et al (2008b). Methamphetamine Alters Blood Brain Barrier Permeability via the Modulation of Tight junction Expression: Implication for HIV-1 Neuropathogenesis in the Context of Drug Abuse. Brain Res.1203, 133–148. 10.1016/j.brainres.2008.01.093
102
MahajanS. D.AalinkeelR.SykesD. E.ReynoldsJ. L.BindukumarB.FernandezS. F.et al (2008a). Tight junction Regulation by Morphine and HIV-1 Tat Modulates Blood-Brain Barrier Permeability. J. Clin. Immunol.28 (5), 528–541. 10.1007/s10875-008-9208-1
103
MandellK. J.BabbinB. A.NusratA.ParkosC. A. (2005). Junctional Adhesion Molecule 1 Regulates Epithelial Cell Morphology through Effects on β1 Integrins and Rap1 Activity. J. Biol. Chem.280 (12), 11665–11674. 10.1074/jbc.M412650200
104
MandellK.ParkosC. (2005). The JAM Family of Proteins. Adv. Drug Deliv. Rev.57 (6), 857–867. 10.1016/j.addr.2005.01.005
105
MandicourtG.IdenS.EbnetK.Aurrand-LionsM.ImhofB. A. (2007). JAM-C Regulates Tight Junctions and Integrin-Mediated Cell Adhesion and Migration. J. Biol. Chem.282 (3), 1830–1837. 10.1074/jbc.M605666200
106
ManesT. D.PoberJ. S. (2011). Identification of Endothelial Cell Junctional Proteins and Lymphocyte Receptors Involved in Transendothelial Migration of Human Effector Memory CD4+ T Cells. J.I.186 (3), 1763–1768. 10.4049/jimmunol.1002835
107
Martin-BlondelG.PignoletB.TietzS.YshiiL.GebauerC.PerinatT.et al (2015). Migration of Encephalitogenic CD8 T Cells into the central Nervous System Is Dependent on the α4β1-integrin. Eur. J. Immunol.45 (12), 3302–3312. 10.1002/eji.201545632
108
Martìn-PaduraI.LostaglioS.SchneemannM.WilliamsL.RomanoM.FruscellaP.et al (1998). Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily that Distributes at Intercellular Junctions and Modulates Monocyte Transmigration. J. Cel. Biol.142 (1), 117–127. 10.1083/jcb.142.1.117
109
Mateos-QuirosC. M.Garrido-JimenezS.Álvarez-HernánG.Diaz-ChamorroS.Barrera-LopezJ. F.Francisco-MorcilloJ.et al (2021). Junctional Adhesion Molecule 3 Expression in the Mouse Airway Epithelium Is Linked to Multiciliated Cells. Front. Cel Dev. Biol.9, 622515. 10.3389/fcell.2021.622515
110
McSherryE. A.BrennanK.HudsonL.HillA. D.HopkinsA. M. (2011). Breast Cancer Cell Migration Is Regulated through Junctional Adhesion Molecule-A-Mediated Activation of Rap1 GTPase. Breast Cancer Res.13 (2), R31. 10.1186/bcr2853
111
McSherryE. A.McGeeS. F.JirstromK.DoyleE. M.BrennanD. J.LandbergG.et al (2009). JAM-A Expression Positively Correlates with Poor Prognosis in Breast Cancer Patients. Int. J. Cancer125 (6), 1343–1351. 10.1002/ijc.24498
112
MengM.KlingensmithN. J.LiangZ.LyonsJ. D.FayK. T.ChenC.-w.et al (2019). Regulators of Intestinal Epithelial Migration in Sepsis. Shock51 (1), 88–96. 10.1097/shk.0000000000001117
113
MirzaM.HreinssonJ.StrandM.-L.HovattaO.SöderO.PhilipsonL.et al (2006). Coxsackievirus and Adenovirus Receptor (CAR) Is Expressed in Male Germ Cells and Forms a Complex with the Differentiation Factor JAM-C in Mouse Testis. Exp. Cel Res.312 (6), 817–830. 10.1016/j.yexcr.2005.11.030
114
MonteiroA. C.LuissintA.-C.SumaginR.LaiC.VielmuthF.WolfM. F.et al (2014). Trans-dimerization of JAM-A Regulates Rap2 and Is Mediated by a Domain that Is Distinct from the Cis-Dimerization Interface. MBoC25 (10), 1574–1585. 10.1091/mbc.E14-01-0018
115
MoriconiF.MalikI.AhmadG.DudasJ.Rave-FränkM.VorwerkH.et al (2009). Effect of Irradiation on Gene Expression of Rat Liver Adhesion Molecules. Strahlenther Onkol185 (7), 460–468. 10.1007/s00066-009-1964-1
116
MortonP. E.HicksA.Ortiz-ZapaterE.RaghavanS.PikeR.NobleA.et al (2016). TNFα Promotes CAR-dependent Migration of Leukocytes across Epithelial Monolayers. Sci. Rep.6, 26321. 10.1038/srep26321
117
MuellerM.HerzogC.LarmannJ.SchmitzM.Hilfiker-KleinerD.GessnerJ. E.et al (2013). The Receptor for Activated Complement Factor 5 (C5aR) Conveys Myocardial Ischemic Damage by Mediating Neutrophil Transmigration. Immunobiology218 (9), 1131–1138. 10.1016/j.imbio.2013.03.006
118
MurakamiM.FrancavillaC.TorselliI.CoradaM.MaddalunoL.SicaA.et al (2010). Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration. Cancer Res.70 (5), 1759–1765. 10.1158/0008-5472.Can-09-1703
119
MurakamiT.TakasawaA.TakasawaK.AkimotoT.AoyamaT.MagaraK.et al (2021). Aberrant Expression of Junctional Adhesion molecule‐A Contributes to the Malignancy of Cervical Adenocarcinoma by Interaction with Poliovirus receptor/CD155. Cancer Sci.112 (2), 906–917. 10.1111/cas.14734
120
NagamatsuG.OhmuraM.MizukamiT.HamaguchiI.HirabayashiS.YoshidaS.et al (2006). A CTX Family Cell Adhesion Molecule, JAM4, Is Expressed in Stem Cell and Progenitor Cell Populations of Both Male Germ Cell and Hematopoietic Cell Lineages. Mol. Cel Biol26 (22), 8498–8506. 10.1128/mcb.01502-06
121
NaikM. U.NaikT. U.SuckowA. T.DuncanM. K.NaikU. P. (2008). Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion. Cancer Res.68 (7), 2194–2203. 10.1158/0008-5472.Can-07-3057
122
NaikM. U.NaikU. P. (2006). Junctional Adhesion Molecule-A-Induced Endothelial Cell Migration on Vitronectin Is Integrin αvβ3 Specific. J. Cel Sci119 (Pt 3), 490–499. 10.1242/jcs.02771
123
NaikM. U.VuppalanchiD.NaikU. P. (2003). Essential Role of Junctional Adhesion Molecule-1 in Basic Fibroblast Growth Factor-Induced Endothelial Cell Migration. Atvb23 (12), 2165–2171. 10.1161/01.Atv.0000093982.84451.87
124
NaikU. P.NaikM. U. (2008). Putting the Brakes on Cancer Cell Migration. Cel Adhes. Migration2 (4), 249–251. 10.4161/cam.2.4.6753
125
NaydenovN. G.JoshiS.FeyginA.SainiS.LitovchickL.IvanovA. I. (2018). A Membrane Fusion Protein, Ykt6, Regulates Epithelial Cell Migration via microRNA-Mediated Suppression of Junctional Adhesion Molecule A. Cell Cycle17 (14), 1812–1831. 10.1080/15384101.2018.1496755
126
OrlandellaF. M.MarinielloR. M.IervolinoP. L. C.AulettaL.De StefanoA. E.UgoliniC.et al (2019). Junctional Adhesion Molecule-A Is Down-Regulated in Anaplastic Thyroid Carcinomas and Reduces Cancer Cell Aggressiveness by Modulating P53 and GSK3 α/β Pathways. Mol. Carcinog58 (7), 1181–1193. 10.1002/mc.23001
127
OrlovaV. V.EconomopoulouM.LupuF.SantosoS.ChavakisT. (2006). Junctional Adhesion Molecule-C Regulates Vascular Endothelial Permeability by Modulating VE-Cadherin-Mediated Cell-Cell Contacts. J. Exp. Med.203 (12), 2703–2714. 10.1084/jem.20051730
128
OstermannG.FraemohsL.BaltusT.SchoberA.LietzM.ZerneckeA.et al (2005). Involvement of JAM-A in Mononuclear Cell Recruitment on Inflamed or Atherosclerotic Endothelium. Atvb25 (4), 729–735. 10.1161/01.ATV.0000157154.14474.3b
129
OstermannG.WeberK. S. C.ZerneckeA.SchröderA.WeberC. (2002). JAM-1 Is a Ligand of the β2 Integrin LFA-1 Involved in Transendothelial Migration of Leukocytes. Nat. Immunol.3 (2), 151–158. 10.1038/ni755
130
OzakiH.IshiiK.HoriuchiH.AraiH.KawamotoT.OkawaK.et al (1999). Cutting Edge: Combined Treatment of TNF-Alpha and IFN-Gamma Causes Redistribution of Junctional Adhesion Molecule in Human Endothelial Cells. J. Immunol.163 (2), 553–557.
131
PalmerG.BussoN.Aurrand-LionsM.Talabot-AyerD.Chobaz-PéclatV.ZimmerliC.et al (2007). Expression and Function of Junctional Adhesion Molecule-C in Human and Experimental Arthritis. Arthritis Res. Ther.9 (4), R65. 10.1186/ar2223
132
PalmeriD.van ZanteA.HuangC.-C.HemmerichS.RosenS. D. (2000). Vascular Endothelial junction-associated Molecule, a Novel Member of the Immunoglobulin Superfamily, Is Localized to Intercellular Boundaries of Endothelial Cells. J. Biol. Chem.275 (25), 19139–19145. 10.1074/jbc.M003189200
133
PariseL. V. (2003). JAM-1 Regulation of Endothelial Cell Migration: Implications for Angiogenesis. Atvb23 (12), 2119–2120. 10.1161/01.atv.0000102926.54780.e7
134
PeddibhotlaS. S. D.BrinkmannB. F.KummerD.TuncayH.NakayamaM.AdamsR. H.et al (2013). Tetraspanin CD9 Links Junctional Adhesion Molecule-A to αvβ3 Integrin to Mediate Basic Fibroblast Growth Factor-specific Angiogenic Signaling. MBoC24 (7), 933–944. 10.1091/mbc.E12-06-0481
135
PellegriniM.ClapsG.OrlovaV. V.BarriosF.DolciS.GeremiaR.et al (2011). Targeted JAM-C Deletion in Germ Cells by Spo11-Controlled Cre Recombinase. J. Cel Sci124 (Pt 1), 91–99. 10.1242/jcs.072959
136
PfeifferF.KumarV.ButzS.VestweberD.ImhofB. A.SteinJ. V.et al (2008). Distinct Molecular Composition of Blood and Lymphatic Vascular Endothelial Cell Junctions Establishes Specific Functional Barriers within the Peripheral Lymph Node. Eur. J. Immunol.38 (8), 2142–2155. 10.1002/eji.200838140
137
PolisettiN.ZenkelM.Menzel-SeveringJ.KruseF. E.Schlötzer-SchrehardtU. (2016). Cell Adhesion Molecules and Stem Cell-Niche-Interactions in the Limbal Stem Cell Niche. Stem Cells34 (1), 203–219. 10.1002/stem.2191
138
QiL.LiuJ.ZhuH.LiZ.LuK.LiT.et al (2014). Inhibition of Glioma Proliferation and Migration by Magnetic Nanoparticle Mediated JAM-2 Silencing. J. Mater. Chem. B2 (41), 7168–7175. 10.1039/c4tb00954a
139
QiL.ShaoW.ShiD. (2013). JAM-2 siRNA Intracellular Delivery and Real-Time Imaging by Proton-Sponge Coated Quantum Dots. J. Mater. Chem. B1 (5), 654–660. 10.1039/c2tb00027j
140
RabquerB. J.AminM. A.TeegalaN.ShaheenM. K.TsouP.-S.RuthJ. H.et al (2010). Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis. J.I.185 (3), 1777–1785. 10.4049/jimmunol.1000556
141
RabquerB. J.PakozdiA.MichelJ. E.GujarB. S.HainesG. K.ImhofB. A.et al (2008). Junctional Adhesion Molecule C Mediates Leukocyte Adhesion to Rheumatoid Arthritis Synovium. Arthritis Rheum.58 (10), 3020–3029. 10.1002/art.23867
142
RohS.-E.JeongY.KangM.-H.BaeY.-S. (2018). Junctional Adhesion Molecules Mediate Transendothelial Migration of Dendritic Cell Vaccine in Cancer Immunotherapy. Cancer Lett.434, 196–205. 10.1016/j.canlet.2018.07.029
143
SarkarO.XiaW.MrukD. D. (2006). Adjudin-mediated junction Restructuring in the Seminiferous Epithelium Leads to Displacement of Soluble Guanylate Cyclase from Adherens Junctions. J. Cel. Physiol.208 (1), 175–187. 10.1002/jcp.20651
144
ScheiermannC.ColomB.MedaP.PatelN. S. A.VoisinM.-B.MarrelliA.et al (2009). Junctional Adhesion Molecule-C Mediates Leukocyte Infiltration in Response to Ischemia Reperfusion Injury. Atvb29 (10), 1509–1515. 10.1161/atvbaha.109.187559
145
SchenkelA. R.MamdouhZ.MullerW. A. (2004). Locomotion of Monocytes on Endothelium Is a Critical Step during Extravasation. Nat. Immunol.5 (4), 393–400. 10.1038/ni1051
146
SchmittM. M. N.FraemohsL.HackengT. M.WeberC.KoenenR. R. (2014a). Atherogenic Mononuclear Cell Recruitment Is Facilitated by Oxidized Lipoprotein-Induced Endothelial Junctional Adhesion Molecule-A Redistribution. Atherosclerosis234 (2), 254–264. 10.1016/j.atherosclerosis.2014.03.014
147
SchmittM. M. N.MegensR. T. A.ZerneckeA.BidzhekovK.van den AkkerN. M.RademakersT.et al (2014b). Endothelial Junctional Adhesion Molecule-A Guides Monocytes into Flow-dependent Predilection Sites of Atherosclerosis. Circulation129 (1), 66–76. 10.1161/circulationaha.113.004149
148
ScottD. W.TolbertC. E.BurridgeK. (2016). Tension on JAM-A Activates RhoA via GEF-H1 and P115 RhoGEF. MBoC27 (9), 1420–1430. 10.1091/mbc.E15-12-0833
149
ScottD. W.TolbertC. E.GrahamD. M.WittchenE.BearJ. E.BurridgeK. (2015). N-glycosylation Controls the Function of Junctional Adhesion Molecule-A. MBoC26 (18), 3205–3214. 10.1091/mbc.E14-12-1604
150
SeversonE. A.JiangL.IvanovA. I.MandellK. J.NusratA.ParkosC. A. (2008). Cis-dimerization Mediates Function of Junctional Adhesion Molecule A. MBoC19 (5), 1862–1872. 10.1091/mbc.e07-09-0869
151
SeversonE. A.LeeW. Y.CapaldoC. T.NusratA.ParkosC. A. (2009). Junctional Adhesion Molecule A Interacts with Afadin and PDZ-GEF2 to Activate Rap1A, Regulate β1 Integrin Levels, and Enhance Cell Migration. MBoC20 (7), 1916–1925. 10.1091/mbc.e08-10-1014
152
SeversonE. A.ParkosC. A. (2009a). Mechanisms of Outside-In Signaling at the Tight junction by Junctional Adhesion Molecule A. Ann. N.Y Acad. Sci.1165, 10–18. 10.1111/j.1749-6632.2009.04034.x
153
SeversonE. A.ParkosC. A. (2009b). Structural Determinants of Junctional Adhesion Molecule A (JAM-A) Function and Mechanisms of Intracellular Signaling. Curr. Opin. Cel. Biol.21 (5), 701–707. 10.1016/j.ceb.2009.06.005
154
ShaoM.GhoshA.CookeV. G.NaikU. P.Martin-DeLeonP. A. (2008). JAM-A Is Present in Mammalian Spermatozoa where it Is Essential for normal Motility. Develop. Biol.313 (1), 246–255. 10.1016/j.ydbio.2007.10.013
155
ShengS.HuY.YuF.TongW.WangS.CaiY.et al (2020). circKIF4A Sponges miR-127 to Promote Ovarian Cancer Progression. Aging12 (18), 17921–17929. 10.18632/aging.103389
156
SircarM.BradfieldP. F.Aurrand-LionsM.FishR. J.AlcaideP.YangL.et al (2007). Neutrophil Transmigration under Shear Flow Conditions In Vitro Is Junctional Adhesion Molecule-C Independent. J. Immunol.178 (9), 5879–5887. 10.4049/jimmunol.178.9.5879
157
SladojevicN.StamatovicS. M.KeepR. F.GrailerJ. J.SarmaJ. V.WardP. A.et al (2014). Inhibition of Junctional Adhesion Molecule-A/LFA Interaction Attenuates Leukocyte Trafficking and Inflammation in Brain Ischemia/reperfusion Injury. Neurobiol. Dis.67, 57–70. 10.1016/j.nbd.2014.03.010
158
SolimandoA. G.BrandlA.MattenheimerK.GrafC.RitzM.RuckdeschelA.et al (2018). JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma. Leukemia32 (3), 736–743. 10.1038/leu.2017.287
159
StamatovicS. M.JohnsonA. M.SladojevicN.KeepR. F.AndjelkovicA. V. (2017). Endocytosis of Tight junction Proteins and the Regulation of Degradation and Recycling. Ann. N.Y. Acad. Sci.1397 (1), 54–65. 10.1111/nyas.13346
160
StamatovicS. M.SladojevicN.KeepR. F.AndjelkovicA. V. (2012). Relocalization of Junctional Adhesion Molecule A during Inflammatory Stimulation of Brain Endothelial Cells. Mol. Cell Biol.32 (17), 3414–3427. 10.1128/mcb.06678-11
161
SuL.ChengC. Y.MrukD. D. (2009). Drug Transporter, P-Glycoprotein (MDR1), Is an Integrated Component of the Mammalian Blood-Testis Barrier. Int. J. Biochem. Cel Biol.41 (12), 2578–2587. 10.1016/j.biocel.2009.08.015
162
SultanaT.HouM.StukenborgJ.-B.TöhönenV.InzunzaJ.ChaginA. S.et al (2014). Mice Depleted of the Coxsackievirus and Adenovirus Receptor Display normal Spermatogenesis and an Intact Blood-Testis Barrier. Reproduction (Cambridge, England)147 (6), 875–883. 10.1530/rep-13-0653
163
TangF.LiJ.XieW.MoY.OuyangL.ZhaoF.et al (2021). Bioactive Glass Promotes the Barrier Functional Behaviors of Keratinocytes and Improves the Re-epithelialization in Wound Healing in Diabetic Rats. Bioactive Mater.6 (10), 3496–3506. 10.1016/j.bioactmat.2021.02.041
164
TarulliG. A.MeachemS. J.SchlattS.StantonP. G. (2008). Regulation of Testicular Tight Junctions by Gonadotrophins in the Adult Djungarian Hamster In Vivo. Reproduction (Cambridge, England)135 (6), 867–877. 10.1530/rep-07-0572
165
TarulliG. A.StantonP. G.LovelandK. L.MeytsE. R.-D.McLachlanR. I.MeachemS. J. (2013). A Survey of Sertoli Cell Differentiation in Men after Gonadotropin Suppression and in Testicular Cancer. Spermatogenesis3 (1), e24014. 10.4161/spmg.24014
166
TenanM.Aurrand-LionsM.WidmerV.AlimentiA.BurkhardtK.LazeyrasF.et al (2009). Cooperative Expression of Junctional Adhesion Molecule-C and -B Supports Growth and Invasion of Glioma. Glia58 (5), NA. 10.1002/glia.20941
167
ThölmannS.SeebachJ.OtaniT.FlorinL.SchnittlerH.GerkeV.et al (2022). JAM-A Interacts with α3β1 Integrin and Tetraspanins CD151 and CD9 to Regulate Collective Cell Migration of Polarized Epithelial Cells. Cell. Mol. Life Sci.79 (2), 88. 10.1007/s00018-022-04140-5
168
TianY.TianY.ZhangW.WeiF.YangJ.LuoX.et al (2015). Junctional Adhesion Molecule-A, an Epithelial-Mesenchymal Transition Inducer, Correlates with Metastasis and Poor Prognosis in Human Nasopharyngeal Cancer. Carcinogenesis36 (1), 41–48. 10.1093/carcin/bgu230
169
TietzS.PérinatT.GreeneG.EnzmannG.DeutschU.AdamsR.et al (2018). Lack of Junctional Adhesion Molecule (JAM)-B Ameliorates Experimental Autoimmune Encephalomyelitis. Brain Behav. Immun.73, 3–20. 10.1016/j.bbi.2018.06.014
170
TornavacaO.ChiaM.DuftonN.AlmagroL. O.ConwayD. E.RandiA. M.et al (2015). ZO-1 Controls Endothelial Adherens Junctions, Cell-Cell Tension, Angiogenesis, and Barrier Formation. J. Cel. Biol.208 (6), 821–838. 10.1083/jcb.201404140
171
TsouP. S.CoitP.KilianN. C.SawalhaA. H. (2018). EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion through Junctional Adhesion Molecule A in Lupus Patients. Arthritis Rheumatol.70 (1), 98–108. 10.1002/art.40338
172
Vences-CatalánF.RajapaksaR.KuoC.-C.MillerC. L.LeeA.RamaniV. C.et al (2021). Targeting the Tetraspanin CD81 Reduces Cancer Invasion and Metastasis. Proc. Natl. Acad. Sci. USA118 (24), e2018961118. 10.1073/pnas.2018961118
173
VerdinoP.WitherdenD. A.FergusonM. S.CorperA. L.SchiefnerA.HavranW. L.et al (20111993). Molecular Insights into γδ T Cell Costimulation by an Anti-JAML Antibody. Structure19 (1), 80–89. 10.1016/j.str.2010.10.007
174
VonlaufenA.Aurrand-LionsM.PastorC.LamagnaC.HadengueA.ImhofB.et al (2006). The Role of Junctional Adhesion Molecule C (JAM-C) in Acute Pancreatitis. J. Pathol.209 (4), 540–548. 10.1002/path.2007
175
WangC. Q. F.ChengC. Y. (2007). A Seamless Trespass: Germ Cell Migration across the Seminiferous Epithelium during Spermatogenesis. J. Cel. Biol.178 (4), 549–556. 10.1083/jcb.200704061
176
WangC. Q. F.MrukD. D.LeeW. M.ChengC. Y. (2007). Coxsackie and Adenovirus Receptor (CAR) Is a Product of Sertoli and Germ Cells in Rat Testes Which Is Localized at the Sertoli-Sertoli and Sertoli-Germ Cell Interface. Exp. Cel Res.313 (7), 1373–1392. 10.1016/j.yexcr.2007.01.017
177
WangY.LuiW.-Y. (2009). Opposite Effects of Interleukin-1α and Transforming Growth Factor-Β2 Induce Stage-specific Regulation of Junctional Adhesion Molecule-B Gene in Sertoli Cells. Endocrinology150 (5), 2404–2412. 10.1210/en.2008-1239
178
WangY.ZhengJ.HanY.ZhangY.SuL.HuD.et al (2018). JAM-A Knockdown Accelerates the Proliferation and Migration of Human Keratinocytes, and Improves Wound Healing in Rats via FAK/Erk Signaling. Cel Death Dis9 (9), 848. 10.1038/s41419-018-0941-y
179
WeberD. A.SumaginR.McCallI. C.LeoniG.NeumannP. A.AndargachewR.et al (2014). Neutrophil-derived JAML Inhibits Repair of Intestinal Epithelial Injury during Acute Inflammation. Mucosal Immunol.7 (5), 1221–1232. 10.1038/mi.2014.12
180
WilliamsD. W.AnastosK.MorgelloS.BermanJ. W. (2015). JAM-A and ALCAM Are Therapeutic Targets to Inhibit Diapedesis across the BBB of CD14+CD16+monocytes in HIV-Infected Individuals. J. Leukoc. Biol.97 (2), 401–412. 10.1189/jlb.5A0714-347R
181
WilliamsD. W.CalderonT. M.LopezL.Carvallo-TorresL.GaskillP. J.EugeninE. A.et al (2013). Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS One8 (7), e69270. 10.1371/journal.pone.0069270
182
WilliamsL. A.Martin-PaduraI.DejanaE.HoggN.SimmonsD. L. (1999). Identification and Characterisation of Human Junctional Adhesion Molecule (JAM). Mol. Immunol.36 (17), 1175–1188. 10.1016/s0161-5890(99)00122-4
183
WitherdenD. A.VerdinoP.RiederS. E.GarijoO.MillsR. E.TeytonL.et al (2010). The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial γδ T Cell Activation. Science329 (5996), 1205–1210. 10.1126/science.1192698
184
WojcikiewiczE. P.KoenenR. R.FraemohsL.MinkiewiczJ.AzadH.WeberC.et al (2009). LFA-1 Binding Destabilizes the JAM-A Homophilic Interaction during Leukocyte Transmigration. Biophysical J.96 (1), 285–293. 10.1529/biophysj.108.135491
185
WongE. W. P.MrukD. D.LeeW. M.ChengC. Y. (2008). Par3/Par6 Polarity Complex Coordinates Apical Ectoplasmic Specialization and Blood-Testis Barrier Restructuring during Spermatogenesis. Proc. Natl. Acad. Sci.105 (28), 9657–9662. 10.1073/pnas.0801527105
186
WoodfinA.ReichelC. A.KhandogaA.CoradaM.VoisinM.-B.ScheiermannC.et al (2007). JAM-A Mediates Neutrophil Transmigration in a Stimulus-specific Manner In Vivo: Evidence for Sequential Roles for JAM-A and PECAM-1 in Neutrophil Transmigration. Blood110 (6), 1848–1856. 10.1182/blood-2006-09-047431
187
WoodfinA.VoisinM.-B.BeyrauM.ColomB.CailleD.DiapouliF.-M.et al (2011). The Junctional Adhesion Molecule JAM-C Regulates Polarized Transendothelial Migration of Neutrophils In Vivo. Nat. Immunol.12 (8), 761–769. 10.1038/ni.2062
188
WoodfinA.VoisinM.-B.ImhofB. A.DejanaE.EngelhardtB.NoursharghS. (2009). Endothelial Cell Activation Leads to Neutrophil Transmigration as Supported by the Sequential Roles of ICAM-2, JAM-A, and PECAM-1. Blood113 (24), 6246–6257. 10.1182/blood-2008-11-188375
189
WuD.ZengY.FanY.WuJ.MulatibiekeT.NiJ.et al (2016). Reverse-migrated Neutrophils Regulated by JAM-C Are Involved in Acute Pancreatitis-Associated Lung Injury. Sci. Rep.6, 20545. 10.1038/srep20545
190
WuK. Z.LiK.GalileoD. S.Martin-DeLeonP. A. (2017). Junctional Adhesion Molecule A: Expression in the Murine Epididymal Tract and Accessory Organs and Acquisition by Maturing Sperm. Mol. Hum. Reprod.23 (2), 132–140. 10.1093/molehr/gaw082
191
WuM.GuoX.YangL.WangY.TangY.YangY.et al (2014). Mesenchymal Stem Cells with Modification of Junctional Adhesion Molecule a Induce Hair Formation. Stem Cell Transl Med3 (4), 481–488. 10.5966/sctm.2013-0165
192
WuM.JiS.XiaoS.KongZ.FangH.ZhangY.et al (2015). JAM-A Promotes Wound Healing by Enhancing Both Homing and Secretory Activities of Mesenchymal Stem Cells. Clin. Sci. (Lond).129 (7), 575–588. 10.1042/cs20140735
193
XiaW.MrukD. D.ChengC. Y. (2007). C-type Natriuretic Peptide Regulates Blood-Testis Barrier Dynamics in Adult Rat Testes. Proc. Natl. Acad. Sci.104 (10), 3841–3846. 10.1073/pnas.0610100104
194
XiaW.WongE. W. P.MrukD. D.ChengC. Y. (2009). TGF-β3 and TNFα Perturb Blood-Testis Barrier (BTB) Dynamics by Accelerating the Clathrin-Mediated Endocytosis of Integral Membrane Proteins: A New Concept of BTB Regulation during Spermatogenesis. Develop. Biol.327 (1), 48–61. 10.1016/j.ydbio.2008.11.028
195
YanH. H. N.ChengC. Y. (2005). Blood-testis Barrier Dynamics Are Regulated by an Engagement/disengagement Mechanism between Tight and Adherens Junctions via Peripheral Adaptors. Proc. Natl. Acad. Sci.102 (33), 11722–11727. 10.1073/pnas.0503855102
196
YanH. H. N.MrukD. D.LeeW. M.ChengC. Y. (2007). Ectoplasmic Specialization: a Friend or a Foe of Spermatogenesis?Bioessays29 (1), 36–48. 10.1002/bies.20513
197
YanH. H. N.MrukD. D.LeeW. M.Yan ChengC. (2008). Blood‐testis Barrier Dynamics Are Regulated by Testosterone and Cytokinesviatheir Differential Effects on the Kinetics of Protein Endocytosis and Recycling in Sertoli Cells. FASEB j.22 (6), 1945–1959. 10.1096/fj.06-070342
198
YangW.-R.LiB.-B.HuY.ZhangL.WangX.-Z. (2020). Oxidative Stress Mediates Heat-Induced Changes of Tight junction Proteins in Porcine Sertoli Cells via Inhibiting CaMKKβ-AMPK Pathway. Theriogenology142, 104–113. 10.1016/j.theriogenology.2019.09.031
199
YangW.YinR.ZhuX.YangS.WangJ.ZhouZ.et al (2021). Mesenchymal Stem-Cell-Derived Exosomal miR-145 Inhibits Atherosclerosis by Targeting JAM-A. Mol. Ther. - Nucleic Acids23, 119–131. 10.1016/j.omtn.2020.10.037
200
YeP.YuH.SimonianM.HunterN. (2011). Ligation of CD24 Expressed by Oral Epithelial Cells Induces Kinase Dependent Decrease in Paracellular Permeability Mediated by Tight junction Proteins. Biochem. Biophysical Res. Commun.412 (1), 165–169. 10.1016/j.bbrc.2011.07.067
201
ZenK.BabbinB. A.LiuY.WhelanJ. B.NusratA.ParkosC. A. (2004). JAM-C Is a Component of Desmosomes and a Ligand for CD11b/CD18-Mediated Neutrophil Transepithelial Migration. MBoC15 (8), 3926–3937. 10.1091/mbc.e04-04-0317
202
ZenK.LiuY.McCallI. C.WuT.LeeW.BabbinB. A.et al (2005). Neutrophil Migration across Tight Junctions Is Mediated by Adhesive Interactions between Epithelial coxsackie and Adenovirus Receptor and a Junctional Adhesion Molecule-like Protein on Neutrophils. MBoC16 (6), 2694–2703. 10.1091/mbc.e05-01-0036
203
ZerneckeA.LiehnE. A.FraemohsL.von HundelshausenP.KoenenR. R.CoradaM.et al (2006). Importance of Junctional Adhesion Molecule-A for Neointimal Lesion Formation and Infiltration in Atherosclerosis-Prone Mice. Atvb26 (2), e10–3. 10.1161/01.ATV.0000197852.24529.4f
204
ZhangH.YinY.WangG.LiuZ.LiuL.SunF. (2014). Interleukin-6 Disrupts Blood-Testis Barrier through Inhibiting Protein Degradation or Activating Phosphorylated ERK in Sertoli Cells. Sci. Rep.4, 4260. 10.1038/srep04260
205
ZhangW.HeR.ChenS.ZhangL.CaoG.YangW.et al (2020). The JAM-B/c-src/MMP9 Pathway Is Associated with Progression and Regulates the Invasion of Pancreatic Cancer. J. Cancer11 (11), 3246–3255. 10.7150/jca.40953
206
ZhangX.LuiW.-Y. (2015). Transforming Growth Factor-Β3 Regulates Cell junction Restructuring via MAPK-Mediated mRNA Destabilization and Smad-dependent Protein Degradation of Junctional Adhesion Molecule B (JAM-B). Biochim. Biophys. Acta (Bba) - Gene Regul. Mech.1849 (6), 601–611. 10.1016/j.bbagrm.2015.03.005
207
ZhaoZ.VajenT.KarshovskaE.DickhoutA.SchmittM. M.MegensR. T. A.et al (2017). Deletion of Junctional Adhesion Molecule A from Platelets Increases Early-Stage Neointima Formation after Wire Injury in Hyperlipidemic Mice. J. Cel. Mol. Med.21 (8), 1523–1531. 10.1111/jcmm.13083
208
ZhouD.TangW.ZhangY.AnH.-X. (2019). JAM3 Functions as a Novel Tumor Suppressor and Is Inactivated by DNA Methylation in Colorectal Cancer. CmarVol. 11, 2457–2470. 10.2147/cmar.S189937
209
ZimmerliC.LeeB. P. L.PalmerG.GabayC.AdamsR.Aurrand-LionsM.et al (2009). Adaptive Immune Response in JAM-C-Deficient Mice: normal Initiation but Reduced IgG Memory. J. Immunol.182 (8), 4728–4736. 10.4049/jimmunol.0803892
Summary
Keywords
junctional adhesion molecules, cell migration, germ cell, epithelial cells, endothelial cells, leukocytes, cancer cells
Citation
Wang J and Liu H (2022) The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration. Front. Cell Dev. Biol. 10:843671. doi: 10.3389/fcell.2022.843671
Received
26 December 2021
Accepted
10 February 2022
Published
09 March 2022
Volume
10 - 2022
Edited by
Zhichao Fan, UCONN Health, United States
Reviewed by
Cristina Corina Clement, Cornell University, United States
Anuska V Andjelkovic, University of Michigan, United States
Ivana Dusan Pajic-Lijakovic, University of Belgrade, Serbia
Updates
Copyright
© 2022 Wang and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Han Liu, m13187036421@163.com
This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.